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  Interferon (IFN) regulatory factor family member 4 (IRF4) is a transcription factor that 
serves specific roles in transcriptional regulation of IFN responsive genes and is 
indispensable in B- & T-cell differentiation. IRF4 like the other members of the family has 
two major domains- the N-terminal DNA binding domain (DBD) essential for its 
recognition and binding to the Interferon Stimulated Response Element DNA sequence and 
a C-terminal Interferon activation domain (IAD) thought to maintain IRF4 in an auto-
inhibited inactive state and is also critical in its activation. A putative unstructured linker  
xv 
 
 
connects the DBD and IAD. Activation in most members of the IRF family requires 
phosphorylation to induce homo and hetero-dimerization. In contrast, IRF4 functions 
primarily through ternary complex formation involving different proteins including PU.1 
and MyD88. The IRF4IAD has a C-terminal auto-inhibitory region (AIR) that has been 
proposed to physically impede the DBD from interacting with DNA in the absence of its 
binding partner.  
  To understand the activation mechanism in molecular detail we determined the crystal 
structure of the IAD of IRF4 and also performed small-angle X-ray scattering (SAXS) 
studies.  Our data reveals that the surface electrostatics of IAD and presence of additional 
loops confers exclusivity to IRF4 in the IRF family. SAXS studies suggest that the AIR is 
structured and makes interactions with the putative linker. We also performed analytical 
ultracentrifugation studies, fluorescence anisotropy binding experiments and SAXS studies 
on full-length IRF4 as well as on constructs where the first 20 residues, exclusive to IRF4 
or the AIR were removed. We observe that the first 20 residues are critical in decreasing 
the binding affinity of full-length IRF4 to DNA. In addition, the putative linker of IRF4 
connecting the N- and C-termini appears to be a folded domain and interacts with AIR. 
Also, overall full-length IRF4 appears as an elongated molecule and the N- and the C-
terminal domains are arranged on either ends of full-length IRF4. Moreover, there are no 
signs of huge conformational changes in the protein during the activation process. Taken 
together, based on our data we propose that there is no auto-inhibited state for IRF4.  
 
 
 
xvi 
 
 
 
Furthermore, it is the binding affinity of full-length IRF4 that is increased in the presence 
of its binding partner most likely through modest conformational changes.  
  
 
 
 
  
 
Chapter 1 
  
Eukaryotic Transcription Machinery 
 
 
1.01 General Introduction:  
 
 Genes may range in number from 4000-6000 in single-celled prokaryotic or lower 
eukaryotic organisms to about 20-25,000 in higher eukaryotes including humans (Pugh, 
2001), (Gonzaga-Jauregui et al, 2012). Growth, development & survival of all organisms 
depends on the accurate temporally and spatially regulated transcription of the information 
present in DNA into RNA that is in-turn translated to proteins. Regulation of transcription 
is the primary mode to control tissue specific gene expression as well as stimulus specific 
gene activity. These processes require numerous regulatory proteins or transcription 
factors, especially for regulation of eukaryotic genes. Nucleoprotein complexes formed 
between different transcription factors and specific DNA sequences mediate transcription 
activation by protein-protein and protein-DNA interactions (Latchman, 2008), (David S. 
Pederson, 1994).  
Not surprisingly, the transcription machinery of eukaryotic organisms is more complex as 
compared to prokaryotic organisms. In prokaryotes, RNA polymerase along with the 
promoter selectivity exhibiting σ factors function as most important members of the 
transcription regulation machinery. Since in prokaryotes all genes are transcribed by a 
single type of RNA polymerase, distinct sigma factors provide the second level of 
regulation to the transcription system such that only promoters of specific genes are 
1 
  2 
upregulated selectively (Clancy, 2008). A two-step equation summarizes the prokaryotic 
transcription complex formation as follows; 
 
                                                    
where, free RNA polymerase (R) and promoter (P) form a rapid and reversible closed 
complex (RPc) with a thermodynamic dissociation constant of KB that isomerizes to form 
the open complex (RPo) at a rate constant kf  (Kingston and Green, 1994). The isomerized 
open complex is the transcriptionally active form.  
 
1.02 Eukaryotic Transcription: 
 Eukaryotic transcription machinery is more extensive and uses a plethora of transcription 
factors in different permutations to regulate different genes. It requires the orchestrated 
binding of several different kinds of transcription factors to different DNA sequences 
sometimes even several base pairs upstream or downstream of the transcriptional start site. 
Generally, the basal transcription machinery composed of RNA polymerase II, 
Transcription Factor IIA (TFIIA), TFIIB, TFIID, TFIIE, TFIIF, TFIIH and TFIIJ are 
sufficient to ensure low-level or basal transcription of genes in vitro. Additional, increased 
activation of eukaryotic gene expression is mediated through the binding of ‘activators’ 
like GAL4 or Sp1 to specific promoter sequences just upstream of the transcription start 
site. Owing to their function, activators are typically composed of a DNA binding domain 
(DBD) that binds to the specific DNA sequences and an activation domain that is essential 
for transcriptional activation. Activators are known to interact with basal transcription 
  3 
factors and affect the equilibrium association constants (Ka) of one or multiple steps of the 
pre-initiation complex assembly formed between the basal transcription factors and the 
activators. Specifically, they may reduce the dissociation rate of bound transcription 
factors and ensure that an increased proportion of the DNA template has bound pre-
initiation complex during transcription. Furthermore, activators may also induce 
conformational changes to the assembled pre-initiation complex, ensure complex stability 
or outcompete repressive chromatin components that negate activated gene transcription. 
‘Enhancer proteins’ like HMG1 or IRF3 are also activators that bind to DNA enhancer 
sequences several base pairs away from the promoter sequence. Enhancers regulate 
transcription through looping of the DNA and bringing the enhancer complex in close 
proximity to the pre-initiation complex on the promoter. There is yet a third class of 
transcription factors that regulate activator-dependent transcription without directly 
binding to DNA called ‘co-activators’. Co-activators either direct the recruitment of the 
transcription apparatus by activators or function as chromatin remodeling or modifying 
enzymes (Eg: Histone acetyltranscferase). Together with the basal transcription machinery, 
the activators, the enhancers and the co-activators constitute the complex transcription 
apparatus in eukaryotes (Harvey Lodish, 2000), (Naar et al, 2001).   
 Since their discovery in 1970s, extensive research in the field has enabled understanding 
of the general principles of site-specific recognition of DNA sequences by transcription 
factors. It is now well known that the peptide backbone or side chains of transcription 
factors make hydrogen bonds with specific nucleotide bases, especially purine bases in the 
major groove or salt-bridges with the phosphodiester backbone. It is also well established 
  4 
that transcription factors bind as homo- or heteromers to ensure site-specific and high 
affinity binding and frequently bind cooperatively to the DNA often perturbing the overall 
shape of the double helix (Eg: ternary complex-IRF4/PU.1/DNA or Reb1/DNA complex). 
Nevertheless, there is a need for a comprehensive investigation to tease apart the 
characteristic features of individual transcription factor complexes to gain insight into the 
regulation mechanism of specific nucleoprotein complexes.  
 
 1.03 Families of transcription factors:  
  Structural studies of transcription factors have enabled the classification of these DNA 
binding proteins based on the commonly occurring structural motifs and secondary 
structures that are used for site-specific binding to the DNA double helix, (Pabo and Sauer, 
1992).  
 
Helix-turn-helix (HTH): 
 A common feature among the crystal structures of the first DNA-binding proteins like λ 
Cro protein (Anderson et al, 1981), (Ohlendorf et al, 1982) DNA-binding domain of λ 
repressor (Pabo and Lewis, 1982) and E.coli CAP proteins (McKay and Steitz, 1981) was 
the occurrence of a motif composed of a α-helix, a turn and second α-helix (HTH motif). 
HTH motif has since been found in structures of several transcription factors like the lac 
and trp repressors (Kaptein et al, 1985), (Schevitz et al, 1985). It is worth noting that the 
HTH motif cannot fold and function by itself and is a part of a bigger domain. 
Nevertheless, the role of the HTH motif in DNA recognition is extremely important & 
  5 
frequently involves side-chains of residues of the HTH making site-specific hydrogen 
bonds or polar interactions with the major groove of DNA and extensive hydrogen bond as 
well as electrostatic interactions between the protein & the DNA backbone.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
d.
. 
Figure 1. Different structural motifs found in DNA binding proteins. a. 
Helix-turn-helix motif (2P81) b. Zinc finger motif (1SP1) c. Leucine 
zipper motif (1T2K) d. Helix-loop-helix motif (2LFH)  
d
. 
a. b
. 
c. 
Helix Helix 
Turn 
  6 
 
Zinc finger: 
 Another major structural motif found in DNA binding proteins is the zinc-finger motif. 
Eg: MYST family of histone acetyltransferases (2L43) and estrogen receptor (1HCQ). 
These are small protein domains of repeats of 20-30 residues with closely placed cysteines 
and histidines that coordinate zinc atoms to generate a robust and stable structure. Zinc 
finger motifs are sub-divided based on the number of zincs coordinated per domain as well 
as number of cysteines and histidines involved in the coordination Eg: C2H2 fold group, 
the gag knuckle or the treble clef and several others. Zinc fingers are involved in numerous 
cellular processes like transcription, translation, cell proliferation and apoptosis. Zinc 
finger domains recognize DNA through an α-helix and several zinc fingers need to bind 
the DNA sequence simultaneously at different positions to ensure tight binding.  
 
Leucine zipper:  
 A third motif is that of the leucine zipper such as that found in enhanceosomes of ATF-
1/c-Jun (Cyclic-AMP-dependent transcription factor / Transcription factor AP-1) complex 
with IRF3 on interferon beta enhancer (1T2K). Leucine zippers are the DNA binding 
domains of basic leucine-zipper superfamily. Monomeric zippers are long α-helices that 
bind DNA as homodimers or heterodimers. Each monomer has an N-terminus that is basic 
& interacts with the major groove of DNA while the C-terminus is amphipathic with every 
seventh residue being a leucine that forms hydrophobic interactions with the C-terminus of 
another leucine zipper monomer to form coiled coils. The hydrophobic portion of the 
  7 
monomer is thus buried and the hydrophilic side is solvent exposed. bZIP transcription 
factors are important mediators of stress responses, cytokine stimulation and affect several 
developmental processes.  
 
Helix-loop-Helix (HLH): 
 This is another motif that functions as a dimer and are closely related to the leucine zipper 
motifs. HLH motifs contain two helices linked by a loop region. One helix is basic and 
recognizes and binds a hexanucleotide E-box (CACGTG) in the major groove of DNA. 
Dimerization occurs through a hydrophobic second helix and the loop and these regions 
also make some minimal interactions with DNA. HLH motif is present in MyoD 
transcription factors important in muscle differentiation (1MYD) and in CLOCK proteins 
important in maintaining the circadian rhythm (1R8J). 
  In addition to the aforementioned transcription factor families that recognize DNA 
primarily through α-helices, there are some prokaryotic regulatory proteins that use beta 
sheets in the DNA recognition process. Repressors like MetJ (Methionine repressor-
1MJM) and Arc (involved in the switch between lysis & lytic cycle in phages-1PAR) use 
an anti-parallel β-sheet make major contacts with DNA with few additional contacts 
rendered by some α-helices.  
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1.04 Architecture of transcription factor DNA biding sites:  
 Transcription factor binding sites (TFBS) are usually 10-30 nucleotides in length with 
only a few nucleotides conserved that are essential for binding by specific residues of the 
transcription factors. Furthermore, there is a built-in level of lack of specificity such that 
different transcription factors can bind to a single site (Ziegler-Heitbrock et al, 2003). The 
sites have also been fine-tuned to ensure timely dissociation of the transcription factors or 
disassembly of complexes at the end of transcription (Werner, 2009). In addition to 
sequestration of the transcription factors in the cytoplasm in the absence of any induction 
signal for gene expression, methylation of DNA at the cognate sites (Douet et al, 2007) 
(Kim et al, 2003) and more tight packing of DNA following DNA deacytelation (Ling et 
al, 2007) constitute the major modes to ensure context-dependent binding of transcription 
factors. Physical vicinity of binding sites and their relevance to functionality of 
transcription factors has been frequently studied in great detail in several bioinformatics 
studies. It was shown by Smith et al, that homotypic cluster of enhancer sites with 1-8 
copies of the binding site of a single transcription factor can but not always amplify the 
strength of the enhancer for example in case of transcription factors that function as 
heterodimeric complexes (Smith et al, 2013).  The origin of such homotypic clusters with 
several weak sites and few strong sites is evolutionarily more favorable most likely without 
significant change in the functionality of the site (He et al, 2012). Smith et al also showed 
that heterotypic sites composed of two or three to four different binding sites for distinct 
transcription factors are stronger than homotypic sites. Multimerization of single type or 
  9 
different types of transcription factors on such clusters is of significance to ensure potent 
transcription. Although there is a line of thought suggesting that such tandem repeats of 
DNA may serve as ‘decoys’ binding to transcription factors in inhibiting gene expression 
(Lee and Maheshri, 2012).   
 
 
1.05 Activation of Transcription factors in Eukaryotic cells: 
  In eukaryotic cells, modulating the activity of pre-existing transcription factors rather 
than inducing its expression at the time of transcriptional regulation is a rapid & flexible 
means to ensure efficient control of gene expression. With the exception of very few 
signaling molecules that can also act as transcription factors like lactoferrin (He and 
Furmanski, 1995), most signaling molecules indirectly produce an active state of the 
previously inactive transcription factor. Generally, there are four basic mechanisms by 
which the transcription factors may be activated (Figure 2.).  
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Figure 2. Four basic mechanisms of activation of transcription factors  
a. Regulation by binding of ligand (L) b. Regulation by protein-protein interaction.  
c. Regulation by protein modification [Eg: Phosphorylation (P)] d. Regulation by 
protein degradation or processing (Inactive protein is activated by degradation of an 
inhibiting protein or some region of the inactive factor to release the active form  
  11 
 
Regulation by ligand binding: 
 Transcription factors may be activated by direct binding of a signaling molecule. This 
binding event induces a conformational change in the transcription factor and ensures a 
rapid response to an activation signal. The identity of the signaling molecule ranges from a 
metal ion in case of induction of yeast metallothionein gene that responds to copper 
(Thiele, 1992) to oxygen molecules that ensures activation of target genes by transcription 
factors like Yap1 only under high oxygen concentration (Wood et al, 2004) and even 
steroid hormones in the activation of glucocorticoid receptor by  
 
 Regulation by protein-protein interaction: 
 Certain transcription factors remain in the cytoplasm in an inactive state bound to another 
inhibitory protein. One of the most well characterized example of such transcription factors 
is NFκB that activates transcription in mature B-cells or cells treated with 
lipopolysaccharides (LPS) or phorbol esters and not in pre-B cells (Yamamoto and 
Gaynor, 2004), (Hoffmann et al, 2006). The inactive NFκB present in the dimer of 
NFκB/IκB becomes active after IκB is degraded following an upstream signal. 
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Regulation by protein degradation and processing: 
 Degradation of IκB is an important step in the activation of NFκB as mentioned above. 
There are other instances of regulation of transcription factors by protein degradation and 
processing for example, the activation of sterol regulatory element binding protein 
(SREBP) in response to changes in cholesterol levels (Brown and Goldstein, 1997).  
 
Regulation by protein modification:             
 Post-translational modifications (PTMs) are central to the activity of several transcription 
factors. Several such PTMs have been documented including phosphorylation of 
serine/threonine residues, acetylation of lysine residues and addition of ubiquitin. Gene 
activation is frequently dependent on such PTMs to ensure regulation by active 
transcription factors. Phosphorylation by specific kinases is a common mode of activation 
of most members of IRF family of transcription factors. Eg: Phosphorylation of IRF3, 
IRF5 & IRF7. The mechanism has been discussed in detail below. 
 
1.06 Interferon regulatory factor family (IRF family): 
 Interferons (IFN) are cytokines that are important members of cell signaling in the host 
immune system against viral infection. Of the two types of IFNs, type I IFNs (IFNα and 
IFNβ) are produced by several different types of cells like B cells, T cells, macrophages, 
fibroblasts and endothelial cells and type II IFNs (IFNγ) are produced by natural killer 
cells (NK cells) & activated T cells.  
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 Proteins of the IRF family are transcription factors that mediate viral and bacterial induced 
IFN signaling pathways. IRF family members are important regulators of not only host 
defense mechanism but also cell growth and apoptosis. Promoters of genes regulated by 
IRFs have an interferon consensus DNA binding sequence called IFN stimulation 
responsive elements (ISRE). Members of the IRF family have a 115 amino acid N-terminal 
DNA binding domain (DBD) with five conserved tryptophan residues, three of which aid 
in binding of DBD to DNA. Exclusivity in function is bestowed to individual members of 
IRF family their by cell specific expression and by the presence of a C-terminus 
transactivation domain that can interact with other members of the IRF family or other 
transcription factors 
 There are nine members in the murine IRF family- IRF-1 through IRF-9. Some members 
also have different names such as Pip/ICSAT for IRF4, ICSBP for IRF8 and ISGF3γ/p48 
for IRF9. Except for IRF-4 and IRF-8, which are expressed specifically in cells of the 
immune system like dendritic cells and macrophages, the other members of the IRF family 
are ubiquitously expressed in various different cells in eukaryotes. Salient features of 
individual members are tabulated below (Table 1). IRF family members are important 
players in the development and execution of the host defense machinery. IRFs stimulate 
the expression of IFN responsive genes in addition to also regulating IFN expression itself. 
IFN acts as a signaling molecule to relay information downstream of the attacking 
pathogen. In addition, IRFs have been implicated in tumor development (IRF-2) as well as 
tumor suppression (IRF-1).  Post-translational modifications like acetylation (IRF-1 or 
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IRF-7), phosphorylation (IRF-3 or IRF-7) and ubiquitination (IRF-7) are important in 
activation of IRFs.  
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Table 1. Salient features of the different members of IRF family of transcription factors.    
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Activation of IRF family of proteins: 
 Activation of most members of the IRF family requires phosphorylation of specific serine 
residues in the C-terminus of the IAD involved in auto-inhibition that induces 
conformational changes & generates a functional dimer (Figure 3). The best-studied 
member of the IRF family IRF3 is expressed ubiquitously and constitutively in different 
organs and is localized in the cytoplasm as an inactive monomer (Lin et al, 1999). Virus-
induced, IKKε or TBK1 mediated phosphorylation of specific serine-threonine clusters 
leads to dimerization, nuclear localization followed by activation of IFNβ gene (Lin et al, 
1998; Servant et al, 2001; Yoneyama et al, 1998; Sharma et al, 2003; Sankar et al, 2006). 
Phosphorylation of corresponding residues in IRF5 and IRF7 has also been shown to be 
important for activation of the protein following induction of expression upon IRFα/β 
mediated viral infection (Marie et al, 2000; Chen et al, 2008).  
 
 
  
  
 
 
 
 
 
 
Figure 3.  General mechanism of activation of IRF3 & IRF5. The activation is mediated 
through C-terminal phosphorylation induced dimerization.  
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Structural details of the auto-inhibitory region in IRF3 were revealed by the crystal 
structure of the IAD of IRF3 (Qin et al, 2003). Several phosphorylation clusters have been 
identified in the C-terminal extension of IRF3 such as Ser385-Ser386 cluster, Ser396-
Ser398 cluster or Ser402-Thr-404-Ser405 cluster (Yoneyama et al, 1998). Alanine 
mutations of these residues produce an IRF3 protein that is incapable of activation. 
Conversely, phosphomimetic aspartate mutations of Ser396-398 cluster and Ser402-Thr-
404-Ser-406 cluster yield a constitutively active mutant. The crystal structure of auto-
inhibited IRF3-IAD illustrated a system of intermolecular interactions between the N- and 
C-terminal helices that buries a hydrophobic pocket stabilizing a four-helix bundle 
involved in maintaining its inactive state. A co-crystal structure of IRF3 bound to co-
activator CREB binding protein (CBP) revealed that the hydrophobic auto-inhibitory 
elements of IRF3 also provided the binding site for CBP (Qin et al, 2005). Later, the 
crystal structure of a constitutively active phosphomimetic mutant of IRF5 (S430D) was 
solved by Chen et al (Chen et al, 2008). The structure showed that the S430D mutation 
caused the unfolding of some key autoinhibitory elements that exposes the hydrophobic 
pocket that is now available to generate a functional dimer. The structure revealed that 
upon phosphorylation the auto-inhibitory region flips out as compared to the auto-inhibited 
inactive conformation captured for IRF3. Together structural and several biochemical 
studies have aided in detailing the mechanism of activation of the IRF3, IRF5 and IRF7, 
which is shown in the schematic below (Figure 4).  
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IRF4: 
Interestingly, IRF4 (also called PU.1 interacting protein (Pip) or Interferon consensus 
sequence binding protein for activated T-cells (ICSAT) is quite different from other 
members in multiple ways. IRF4 along with IRF8 are the only two members of the IRF 
family that express more restrictively in the macrophages and dendritic cells and to some 
extent in cardiocytes (Jiang et al, 2013) and adipocytes (Eguchi et al, 2011; Fabrizi et al, 
2014) as compared to the ubiquitous cell expression profile of the other members.  
Figure 4.  Schematic representation of activation of IRF3 and IRF5. IAD of IRF5 
undergoes phosphorylation induced dimerization, followed by binding to CBP. IRF5 
binds to its recognition site of DNA as a dimmer. (adapted from (Chen et al, 2008)). IRF3 
and IRF7 also have phosphorylation sites in their C-terminal extension and are believed to 
undergo activation in a similar manner.  
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 Murine IRF4 contains 450 residues and has a DNA binding domain (DBD) of ~119 
residues and an IRF association domain (IAD) spanning 212 amino acids (Figure 4). The 
last 30 residues at the C-terminus have been suggested to be involved in maintaining the 
protein in an auto-inhibited state and conferring low DNA binding ability to the full length 
protein. We will refer to this region as the auto-inhibitory region (AIR). 
 
 
 
 
 
 
  In addition, IRF4 is the only member of the family comprising of a 20 amino acid long N-
terminus extension. Surprisingly, IRF4 is known to interact with multiple different binding 
partners including the leucine-zipper heterodimer BATF-JunB (Li et al, 2012), STAT6, 
(Gupta et al, 1999)  as well as other members of the IRF family with the most well 
characterized binding partner being PU.1 (an ETS family member) (Pongubala et al, 1993; 
Eisenbeis et al, 1993; Perkel and Atchison, 1998; Yee et al, 1998). Although, 
phosphorylation induced homo-dimerization as a mode of activation for IRF4 has been 
suggested (Biswas et al, 2010b), ternary complex formation between IRF4, its binding 
Figure 5. Schematic representation of full length IRF4 including individual domains. 
Represented in cyan is the DBD, in yellow, the putative linker, in pink the IAD and in violet the 
AIR as well as the N-terminal 20 residues.   
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partner and DNA to relieve the auto-inhibited inactive state of IRF4 remains the better-
established mechanism of activation for IRF4 (Figure 5).  
 
 
 
 The well-accepted mechanism of activation of IRF4 involves interaction of IRF4 with a 
binding partner. This interaction is thought to induce conformational changes in the AIR, 
which translates into extensive conformational changes in the full-length protein. The full-
length protein is thought to pivot around a flexible linker that connects the DBD and IAD 
to go from a ‘closed’ to an ‘open’ conformation. It has been suggested that the AIR 
physically interacts with DBD preventing it from binding to the ISRE consensus sequence 
Shown in Figure 6 is the schematic representation of the currently accepted mechanism of 
activation of IRF4 (Brass et al, 1996; 1999).  
 
 
Figure 6. General mechanism of activation of IRF4. The schematic here is not suggestive of 
hetero-dimerization between IRF4 and its binding partner in the absence of DNA. The 
sequence of binding of the different macromolecules and stability of hetero-dimers of IRF4 
with individual binding partner has not been fully investigated yet. 
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1.07 Role of IRF4 in development of the host immunity:  
 Being exclusively expressed in immune cells IRF4 plays key roles in the development of 
the host defense system (Figure 5). In addition to binding to ISRE IRF consensus 
sequence, the ability of IRF4 to partner with several different proteins through protein-
protein interactions extends the range of genes whose regulation is mediated by IRF4. 
IRF4 plays a pivotal role in the plasma cells differentiation from pre-B cells after they 
produce high-affinity antibodies shown using transgenic mice with conditional deletion of 
Irf4 (Klein et al, 2006).  The reach of IRF4 in the development of host immunity is wide 
spread. IRF4 is also important in the differentiation of CD4+ dendritic cells that link the 
innate and adaptive immune systems by functioning as antigen presenting cells (Suzuki et 
al, 2004; Tamura et al, 2005). Although IRF4 has a dispensable role in activation of CD4+ 
T-cells, it has been shown to be important in differentiation of CD4+ T-cells like Th2 and 
Figure 7. Currently accepted mechanism of activation of IRF4 
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Th17 cells (Biswas et al, 2010a). IRF4 was also implicated in the process of cell expansion 
and differentiation of effector CD8+ T-cells, which additionally required a robust T-cell 
receptor (TCR) signaling (Yao et al, 2013). Further, IRF4 also has indirect roles in 
mediating the host immune system. Toll-like receptor (TLR) mediated signaling central to 
the activation of the host immune system involves interaction with MyD88 adaptor 
molecule (Medzhitov et al, 1998). IRF5 and IRF7 interact with MyD88 to ensure induction 
of proinflammatory cytokines & type I IFNs (Honda et al, 2004, 2005; Kawai et al, 2004; 
(Takaoka et al, 2005). IRF4 interacts with MyD88 and negatively regulates the TLR 
signaling by competing with IRF5 and not with IRF7 (Negishi et al, 2005).  
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1.08 IRF4 in progression of diseases: 
 Owing to its diverse interactome, IRF4 is now known to be a major player in the 
progression of multiple disease states like multiple myeloma, ulcerative colitis and certain 
other auto-immune diseases like type 1 diabetes, multiple sclerosis and systemic lupus 
Figure 8.  Importance of IRF4 in development of immune cells . A flow chart showing its role 
in various stages of development of the immune system. Image adapted from (Carrie N. 
Arnold, 2013) 
Dendritic cell 
Macrophage 
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erythematosus (reviewed in Xu et al, 2012). In case of type 1 diabetes there are no animal 
models for studying the development of these auto-immune diseases but deficiency and 
lack of IRF4 in murine models have been shown to improve the prognosis in multiple 
sclerosis and lupus, respectively.   
 
Achilles heel of multiple myeloma:  
 
 IRF4 has been called an ‘Oncogenic Biomarker’ (reviewed in Ning, 2013). As a regulator 
of cell cycle, apoptosis & cell proliferation IRF4 transcriptionally regulates several genes 
like Blimp1, Bcl6 and Myc. Like the other members of the family such as IRF2 and IRF7, 
IRF4 also possesses oncogenic and anti-apoptotic properties and IRF4 driven regulatory 
mechanisms are of significance in hematological malignancies like multiple myeloma 
(MM), activated B-cell like Diffuse Large B-Cell Lymphoma (ABCDLBCL) and other 
proliferative disorders. Over expression of IRF4 in these malignancies serves as a 
diagnostic tool in understanding the progression of the disease. In MM, IRF4 serves as a 
key component in maintenance and progression of the malignancy.  
 Multiple myeloma is malignancy of terminally differentiated B-cells or plasma cells. In 
2008, Shaffer et al (Shaffer et al, 2008) illustrated the oncogenic role of IRF4 in multiple 
myeloma. Due to the indisputable role of IRF4 in B-cell differentiation as well as lethality 
to myeloma cell lines shown with small hairpin RNA based IRF4 inhibition, it has been 
called the ‘Achilles’ heel by the authors. The authors also identified the target of IRF4 in 
activated B-cells and myeloma to be MYC. Moreover, an autoregulatory circuit between 
MYC and IRF4 was described in myeloma cell lines important in the sustenance of the 
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disease. Furthermore, a 50% knockdown of IRF4 mRNA is sufficient to kill myeloma cells 
while mice lacking one allele are phenotypically normal. Thus, being a master regulator of 
multiple myeloma IRF4 presents itself as a viable target for drug design.  
 
IRF4 in ulcerative colitis 
 IRF4 has a well-established role in the development & differentiation of dendritic and T- 
and B-cells (De Silva et al, 2012; Yao et al, 2013). These cells have direct role in the 
pathogenesis of autoimmune diseases like Crohn’s disease or ulcerative colitis and hence a 
correlation of the pathogenesis of these diseases with IRF4 is of significance and is well 
characterized. Proinflammatory cytokines like IL-6 have long been known to be play 
important role in these inflammatory bowel diseases (IBD) but the molecular mechanism 
of their production had remained elusive. It was shown by Mudter et al (Mudter et al, 
2008) that in patients with IBD there was significant over-expression of IRF4 especially in 
lamina propria of CD3+ pro-thymocytes. Trinitrosulfonic acid or oxazolone did not induce 
severe colitis in IRF4 deficient mice and was directly correlated to the decreased 
production of IL-6 in the mucosa. Thus, IRF4 was identified as a key regulator of IL-6 
production as well as pathogenesis of T-cell dependent ulcerative colitis and a probable 
therapeutic target in ulcerative colitis.  
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IRF4 in cardiac hypertrophy: 
 Notwithstanding the incontrovertible role of IRF4 in immune system, its role in cardiac 
hypertophy was recently highlighted by Jiang et al (Jiang et al, 2013). Cardiac hypertrophy 
or increase in cardiomyocites in response to decrease in cardiac output and hemodynamic 
overload has a complicated etiology involving several signaling pathways of G-protein 
coupled receptors , mitogen-activated protein as well as other members of IRF family like 
IRF1 and IRF3 (Rockman et al, 2002; Molkentin and Dorn, 2001; Heineke and Molkentin, 
2006). In case of IRF4, a transgenic mouse model was subjected to aortic banding and it 
was delineated that it was overexpression of IRF4 that increases the pressure overload of 
the heart. The end result is cardiac dysfuntion, fibrosis and cardiac hypertrophy. Acting as 
a transcription factor IRF4 was shown to bind to its specific response element in the 
promoter region of cAMP response element binding protein (CREB) resulting in up-
regulation of CREB. IRF4 may well serve as a selective target for development of novel 
therapeutics for cardiac hypertrophy. 
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Chapter 2 
Crystal structure and small-angle X-ray scattering studies of interferon activation domain 
of IRF4 
 
2.01 Introduction:  
  
 The IAD of IRF family of proteins not only contain the auto-inhibitory elements to 
maintain the proteins in an inactive state but more importantly these domains are involved 
in interaction of IRF proteins with their respective binding partners. The IAD of IRF4 is 
significant in this context. IRF4 is known to bind DNA poorly in the absence of its binding 
partners. IRF4 transcriptionally regulates different genes by forming ternary complexes 
with multiple binding partners binding to DNA composite sites comprising of an IRF DNA 
recognition sequence adjacent to sequence recognized by the partner protein (Figure 1). 
Several such binding partners have been identified including PU.1, Spi-B, NFAT (nuclear 
factor of activated T cell) and E47 (reviewed in De Silva et al, 2012). The IAD of IRF4 
serves as the primary domain involved in interaction with these binding partners and 
additionally the DBD also provides some degree of interaction. A region composed of 
residues 150-340 of IRF4 was determined to be important in interaction of NFAT (Nuclear 
factor of activated T-cells) with IRF4 (Rengarajan et al, 2002; Gupta et al, 2001).  
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b. 
a. 
Figure 1.  Schematic representation of IRF4 and its binding partners a. Schematic 
representation of the regions of IRF4 known to interact with its various binding partners. b. 
Schematic representation of additional binding partners of IRF4 
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Furthermore, residues 140-207 and 300-420 of IRF4 were determined to be important in 
interaction of E47 (E2A immunoglobulin enhancer-binding factors E12/E47) with IRF4. 
DBD of IRF4 was also shown to be important in forming the ternary complex with E47 for 
maximal transcriptional synergy (Nagulapalli and Atchison, 1998). There are more 
examples of binding partners of IRF4 that are being discovered but IAD of IRF4 presents 
as the domain required for the protein-protein interaction. 
 Although, there are some reports of putative phosphorylation sites identified in the C-
terminus of IAD of IRF4, dimerization as a mode of activation has not been established for 
IRF4 yet (Biswas et al, 2010b). The crystal structure of the ternary complex of IRF4 DBD 
with the DBD of PU.1 bound to the composite site of immunoglobulin-λ enhancer is the 
only atomic level structural information available about this member of IRF family 
(Escalante et al, 2002). It highlighted the cooperativity between the two proteins through 
their respective DBDs, which is also important to the activation process. In addition, a 
putative helical region in the IAD from residues 398-400 was identified by Brass et al to 
be important in interaction with PU.1 with Lysine399 described as the key residue for the 
interaction (Brass et al, 1999).  
 Lack of structural and biophysical characterization of IRF4 IAD leaves a great void in our 
understanding of this unique member of IRF family of transcription factors. Sequence 
alignment in the IADs as well as AIR extension of the three proteins, namely IRF3, IRF5 
and IRF4 is quite low. Thus, although there may be an overall similarity in the fold of the 
three proteins, IRF4 presumably has characteristic traits enabling it to function in 
conjunction with a binding partner. One of our important goals is to delineate structurally 
  30 
the molecular details unique to IAD of IRF4 to better understand the interaction of IRF4 
with its binding partner.  
 In an attempt to crystallize the IAD of IRF4 we cloned, expressed and purified the 
construct composed of residues 238-450. This construct proved to be non-ideal for 
crystallization since it aggregated at a concentration of above 2mg/mL. Successful, 
crystallization trials generally require a minimal protein concentration of 10mg/mL. The 
protein was dialyzed in several different buffers including high concentration of reducing 
agents (upto 10mM beta-mercaptoethanol or 2-3mM TCEP) and amino acids like L-
Arginine (upto 400mM) with little success in achieving crystallization hits. Hence, we 
expressed and purified another construct composed of residues 238-420, which was 
amenable to crystallization trials. To obtain structural information on the AIR, we utilized 
solution X-ray scattering studies on IRF4 IAD 238-450 
 
2.02 Results:  
2.02.1 Purification and crystallization: 
 
IRF4IAD1:  
 Mouse IRF4 C-terminus construct 238-420 (IRF4IAD1) was subcloned into pET-15b 
TEV vector (pet15TEV_NESG (EvNO00338203) from DNASU plasmid repository, the 
vector has a Tobacco Etch Virus-protease cleavable site following the 6-His site). The gene 
of interest was PCR amplified using the appropriate primers, restriction digested using two 
restriction enzymes NdeI and BamH1 to ensure directional cloning, ligation and 
transformation into XL10-Gold Escherichai coli cells. Positive clones were sequenced and 
  31 
subsequently transformed into BL21-pLysS* E. coli expression cells. An overnight pre-
culture was grown in Luria-broth media with 100µg/mL amplicilin and 25µg/mL 
chloramphenicol antibiotics at 370C. Next day, 4L of autoclaved LB media was inoculated 
with the pre-culture (20mL per liter), cells were grown at 370C, induced with 0.5mM IPTG 
at OD ~0.6 and harvested after 4hrs. The cells were flash-frozen, thawed and resuspended 
in 25mM Tris-base pH 8.0, 500mM NaCl, 2mM TCEP, 5mM Imidazole, 10% glycerol, 
sonicated and centrifuged at 20000 rpm for 30 mins. Protein was eluted from a Ni-NTA 
column with 300mM Imidazole and the Histidine (His) tag was removed using the home 
grown and purified Tobacco Etch Virus (TEV)-protease (details of purification in 
appendix). The cleaved protein was further purified on Ni-NTA column to remove the His-
tag as well as the TEV-protease followed by gel filtration on a Superdex75 column in 
25mM Tris-base pH 8.0, 300mM NaCl, 2mM TCEP and 5% glycerol. Purified protein was 
concentrated to 16mg/mL (0.753mM) and stored at -800 C in 60µL aliquots.  
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Figure 2.  SDS-gel electrophoresis result of purification of IRF4IAD1 a. SDS-gel 
electrophoresis result of purification of IRF4IAD1 after a Ni-NTA column. b. SDS-gel 
electrophoresis result IRF4IAD1 after cutting with TEV-protease 
b. 
a. 
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Figure 2. SDS-gel electrophoresis result of purification of IRF4IAD1 c. SDS-gel 
electrophoresis result of purification of IRF4IAD1 after second Ni-NTA column. d. 
SDS-gel electrophoresis result after purification of IRF4IAD1 after a gel filtration 
column 
c. 
d
. 
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Initial factorial screens of IRF4IAD1 (at 0.753mM) with Hampton and Emerald 
crystallization screens yielded thin needle shaped crystals in Emerald Wizard Screen I 
condition 37 (2.5M NaCl, 0.1M Imidazole pH 8.0) with hanging drops at 200C. The initial 
crystals grew as a bunch and could not be separated (Figure 3 a.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Images of crystals of IRF4IAD1 a. Initial needle shaped clusters grown at 
200C. b. Thin plate crystals obtained after changing the precipitant from NaCl to KCl. 
c. Single plate crystals obtained after changing the temperature to 40C and precipitant 
to KCl.   
a. b
. 
c. 
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 The precipitant salt was changed from NaCl to KCl and the reservoir concentration was 
reduced to 2M KCl, which resulted in thin plate crystal clusters (Figure 3 b). Further 
optimization of the condition along with a change in crystallization temperature to 4°C 
resulted in single thin plate crystals in surprisingly much lower salt concentration of 1.5-
1.7M KCl, 0.1M Imidazole pH 8.0 as compared to the original condition at 20°C (Figure 3 
c).  
 
IRF4IAD2: 
Mouse IRF4 C-terminus construct 238-450 (IRF4IAD2) was subcloned into pET-15b TEV 
by a procedure similar to that mentioned above using the appropriate primers. IAD was 
also grown at 370C until the OD reached ~0.6, induced with 0.5mM IPTG and harvested 
after 4hrs. Following Ni-NTA based affinity purification detailed above the His-affinity 
tag of IAD was removed using thrombin (1Uthrombin/1U protein) (Figure 4 a and b). 
Thrombin was precipitated with p-aminobenzamidine-agarose beads by continuous 
shaking for 45 mins. Finally IAD was gel purified on a Superdex-75 column in 25mM 
Tris-base pH 8.0, 500mM NaCl, 5mM BME, 10% glycerol (Figure 4 c and d). Protein was 
concentrated to 1mg/mL (0.04mM) and stored in 100µL aliquots since the protein 
precipitated at a concentration above 2mg/mL. 
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Figure 4. SDS-gel electrophoresis result of purification of IRF4IAD2 a. SDS-gel 
electrophoresis result of purification of IRF4IAD2 after Ni-NTA column. b. SDS-gel 
electrophoresis result of IRF4IAD2 after cutting with thrombin protease.  
b. 
a. 
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Figure 4. SDS-gel electrophoresis result of purification of IRF4IAD2 c. SDS-gel 
electrophoresis result of purification of IRF4IAD2 after second Ni-NTA column. d. 
SDS-gel electrophoresis result of purification of IRF4IAD2 after gel filtration column  
d. 
c. 
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2.02.2 Data collection and structure determination:  
 To check the diffraction of the crystals we collected diffraction data on one of the thin 
plate crystals from the clusters that were obtained after initial optimization (Figure 5. b). 
Crystals diffracted to 2.4Å at the home source (Molecular Structure Corporation (MSC) X-
Stream Cryogenic Crystal Cooler with a Rigaku IV ++ image plate detector, and a Rigaku 
MicroMax-007 X-Ray source (copper) fitted with MSC Varimax Confocal optics 
operating at 40 kV and 20 mA). A representative image of an oscillation frame is shown in 
Figure 5. The mother liquor with 25% glycerol served as the cryo-protectant. Initial 
indexing indicated that the crystals were in monoclinic space group and 1800 data were 
collected. A total of 380 frames were collected from φ 0 to 190 at 0.50o intervals at a 
detector distance of 160mm. Data collection statistics for the data collected at home source 
is provided in Table 1. Scaling and averaging of this data was followed by multiple 
unsuccessful attempts to obtain a solution, initial phases and a starting model for IRF4 IAD 
using IRF5 IAD as a search model for molecular replacement in either ccp4 (Winn et al, 
2011) or Phenix (Adams et al, 2010). We concluded that the high mosaicity of the 
collected data indicated by spot overlap (inset Figure 5) might be causing errors in 
indexing, scaling and averaging. Thus, a single solution was not achieved using molecular 
replacement. Furthermore, the quality of the crystal used here was not optimal as it was 
broken off from the cluster of crystals shown in (Figure 3 b). 
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Figure 5. Representative diffraction image of IRF4IAD1with high mosaicity. Inset 
shows closely spaced diffraction spots indicating high mosaicity in the diffraction 
data.  
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 After optimization of the original condition to obtain single crystals, the crystals were 
harvested at 4°C into the reservoir-cryo solution (1.5M-1.7M KCl, 0.1M Imidazole and 
25% glycerol used as a cryoprotectant) and flash-frozen after about 15-20 seconds of 
soaking in the cryo-solution. Diffraction data were collected for multiple single thin-plate 
crystals at beamlines X4A and X25 at National Sychrotron Light Source (NSLS). Initial 
attempts to collect diffraction data at X4A beamline were unsuccessful since indexing did 
Table 1. Data collection statistics for IRF4IAD1 of data collected at home source. 
Statistics for the last shell is shown in brackets.  
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not provide any acceptable spacegroup (Figure 8). We attempted annealing and also 
soaking the crystals in the reservoir-cryo solution for longer periods of time with little 
success. We observed that high degree of mosaicity in the crystals was causing problem 
indexing and further processing. We reasoned that although the crystals appeared single to 
the naked eye they probably were multiple crystals stacked up on each other. We then used 
the micro-focus beam available at both the beamlines to collect data sets from the edges of 
the thin plates crystals where the crystals had a higher probability of being single. Of about 
50 crystals that were screened between the beamlines X4A and X25 only four complete 
data sets with low-mosaicity could be collected between 2.8–2.4Å resolution. A 
representative image of the diffraction data is shown in Figure 8. But at resolutions above 
2.6Å the completeness of the data sets was quite low and hence the data set 2.6Å was only 
used for refinement. Data collection statistics of data set that was used for structure 
solution (data set at 2.8Å) are provided in Table 2. The data sets could be readily indexed 
and gave a spacegroup of P2221.  
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Figure 6. Single representative diffraction image of IRF4IAD1 collected from the 
edges of single crystals.  
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Data collection 
 
IRF4IAD1 
Space group P2221 
Cell dimensions   
    a, b, c (Å) 45.5    84.9   149.9 
    a, b, g  (º) 90    90    90 
Number of reflections 
  
  Total measured  
 
   Unique 
 
 
342484 
 
15281 
 
Resolution (Å) 2.8 
Rmerge 10 (15.6) 
I/σI 8.5 (13.5) 
Completeness (%) 83 (78) 
Table 2. Data collection statistics for IRF4IAD1 of data collected at X-4Abeamline. 
Statistics for the last shell is shown in brackets.  
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2.02.3 Structure determination: 
 The crystal structure of the transactivation domain of IRF4IAD1 was determined at 2.8Å 
using molecular replacement and later refined to 2.6Å. Refinement statistics for IRF4IAD1 
is provided in  (Table 3.).  
Refinement IRF4IAD1 
Resolution (Å) 2.6 
Number of reflections 17122 
Rwork/ Rfree 22.19 / 27.95 
Non hydrogen atoms  
    Protein 2744 
B-factors  
    Protein (Å2)  36 
R.m.s deviations  
    Bond lengths (Å)  0.002 
    Bond angles (º) 0.565 
Ramachandran plot quality  
    Most favored (%) 97.97 
    Generally allowed (%)  1.74 
     Disallowed (%)  0.29 
 
 
Table 3. Refinement statistics for IRF4IAD1 of data collected at X-4A beamline.  
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 The structure was solved by molecular replacement using the structure of IRF5 IAD as a 
search model in the program Phaser in ccp4 ((Adams et al, 2010), (McCoy et al, 2007)), a 
software suite for automated structure solution. The data was cut off to 2.8Å during the 
search to generate a starting model with an acceptable R-factor of less than 50. The starting 
model was then exported to Phenix (Adams et al, 2010) and refinement of the structure 
was performed in Phenix.refine. Manual model corrections including loop building, 
changing the side chain and peptide orientations and addition of missing residues and ions 
was performed after every round of refinement using the improved map and the 
Ramachandran plot (please see appendix -X-ray crystallography glossary; sub-heading: 
Refinement for details). Initial 4-5 rounds of refinement were performed using the 
refinement strategy that included simulated annealing and real space refinement.  
 For subsequent 10 rounds of refinement we used a strategy including the non-
crystallographic symmetry (NCS) in the refinement. In addition, TLS refinement (please 
see appendix section of X-ray crystallography (sub-heading: Refinement) for an 
explanation of this refinement strategy) was also used in these rounds of refinement.  
  A web server was used for generating an input file for TLS motion determination to be 
used in Phenix.refine (Merrit, 2006). After multiple rounds of refinement and addition of 
water molecules to the structure a final Rfactor of 27.95% with the final Rfree of 22.19% was 
obtained. A final Ramachandran plot obtained for the structure is shown in Figure 9.  
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Figure 7. Ramachandran plot of IRF4IAD1 after refinement.  
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2.02.4 X-ray structure of IRF4IAD1: 
 The X-ray structure of IRF4IAD1 contains two polypeptide subunits per asymmetric unit. 
The dimeric arrangement of IRF4IAD1 has no physiological significance but is the result 
of favorable crystal packing. Sedimentation analysis of IRF4IAD1 reveals a monomeric 
state of the protein with no suggestion of possibility of oligomerization (Figure 8)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Sedimentation velocity profile of IRF4IAD1. It shows a single 
peak for the protein with an Sw,20 of 2.0 
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Figure 9. Overview of IRF4IAD1. It represents the four alpha helices, ten beta 
sheets and the associated loops.  
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Figure 10. 2-D representation of the crystal structure of IRF4IAD1.  The various 
secondary elements are clearly visible including the loops that connect them.   
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 The subunit A of the X-ray structure of IRF4IAD1 (Figure 9 and 10) is described 
hereunder. It is composed of four alpha helices (labeled α1-α4) that surround the core of 
beta sheets (labeled β1-β10). Helices α1, α3 and α4 form a helix bundle that is located  
towards the upper end of the structure. There are two beta hairpins in the structure are 
formed by β1-β2 and β5-β6. β3 and β4 are connected by loop Lβ3-β4 of moderate length 
while another such loop Lβ4-α2 connects beta sheet β4 to helix α2. We also observe two 
quite long loops-Lβ7-β8 and Lβ9-β10 that connect beta sheets β7-β8 and β9-β10, respectively.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Superimposition of subunits A and B of IRF4IAD1   
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 Subunits A and B of IRF4IAD1 superimposed with a root mean square deviation (rmsd) 
between the Cαs of 0.56Å using the program Lsqman (Kleywegt and Jones, 1994) 
indicating that the two subunits are quite similar (Figure 11) (Lsqman was used to 
calculate all of the mentioned rmsds). The electron density for loops Lβ7-β8 and Lβ9-β10 is 
missing in subunit B although two extra residues one on either N- and C-termini are visible 
in subunit B and not in subunit A. In addition, Lβ7-β8 in subunit B has some secondary 
structure characteristic shown by the presence of a small beta sheet. The largest difference 
between the two subunits is in the position of helix α1 (rmsd of 3.72Å) between the Cαs of 
the first 12 residues of the N-terminus. This is indicative of appreciable degree of 
flexibility of helix α1. The corresponding helix in IRF3IAD is superimposable between the 
two subunits. This feature seems to be inherent to IRF4.   
  It is worth noting that IRF4IAD1 contains the MH2 fold of the Smad protein family 
shown in Figure 12. Overall, IRF4IAD1 has a contour resembling a claw and although 
there is similarity between the shape of IRF4IAD1 and MH2 domain of Smad3 (1MJS), 
MH2 domain of Smad3 lacks the helix bundle seen in IRF4IAD1, is less bulky and has 
shorter loops. Smad3 also has a Ser-X-Ser motif that gets phosphorylated by its binding 
partner, an activated type II tissue growth factor receptor β (TGFβ receptor) (Huse et al, 
2001), (Wu et al, 2000), (Wu et al, 2001). IRF4IAD1 lacks such phosphorylation sites 
although it binds to multiple binding partners.   
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Figure 12. Comparison of crystal structures of MH2 domain of 
 Smad3 and IRF4IAD1a. MH2 domain of Smad3 (1MJS)  b. 
IRF4IAD1  
a. b. 
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2.04.5 Comparative analysis of IRF4IAD1 with IADs of other members of the IRF family: 
 
IRF4IAD1 and IRF3IAD: 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Superimposition of IRF3IAD (green) and IRF4IAD1 (cyan) 
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 The rmsd between the Cα atoms of IRF4IAD1 (182 residues) and IAD of IRF3 (193 
residues, auto-inhibitory region was removed for the superimposition) is ~1.35Å. There are 
three regions that show major differences between the two structures (Figure 13). There is 
a 5.18Å rmsd between helix α1 of subunit A of IRF4IAD1 with the corresponding 11 Cα 
atoms of IRF3 (6.2Å rmsd between subunit B of IRF4IAD1 and corresponding 11 Cα 
atoms IRF3). Loop Lβ7-β8 of IRF4IAD1 is more structured in the IAD of IRF3 forming two 
beta-sheets and is also in a different orientation (rmsd of 12.24Å and 9.88Å between 
subunit A and subunit B and the corresponding 14 Cα atoms in IRF3, respectively). But 
the major structural difference of physiological relevance is in loop Lβ9-β10 of IRF4IAD1 
(rmsd of 9.66Å and 9.74Å between subunit A and subunit B and the corresponding 14 Cα 
atoms in IRF3, respectively). This loop contains the critical residue lysine399 flanked by 
residues 398-400 on its either side. This region was proposed to form an α-helix in 
previous studies (Brass et al, 1999) but we show here that it is a highly flexible linker that 
forms a positive patch (see below in electrostatics) for making key electrostatic interactions 
with phosphorylated residues of partnering proteins like phosphorylated PU.1. The 
corresponding loop in IAD of IRF3 has some helical character to it, which makes it more 
rigid and thus has lesser degrees of freedom. 
  It is worth noting that the 30 residue C-terminal extension in the IAD of IRF4 has no 
appreciable sequence similarity to the auto-inhibitory region of IRF3 (Figure 14). It is also 
much shorter and lacks residues that may undergo phosphorylation as compared to the key 
phosphorylation sites identified for IRF3. The residues that undergo phoshorylation in IAD 
of IRF3 are labeled in red in Figure 16. Secondary structure of IAD of IRF3 is depicted on 
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top of the sequence. Putative phosphorylation serine residues in IRF4 that have regulate 
IL-17 and IL-21 production in mice are Serine 446 and Serine 447 (Biswas et al, 2010b).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Sequence alignment of IRF3IAD and IRF4IAD1. In red are shown the 
phosphorylation sites of IRF3IAD. In blue are shown the putative phosphorylations site 
sin IRF4IAD1. In cyan are shown the hydrophobic residues of IRF3IAD found in helix 
α5. Corresponding residues are absent for IRF4IAD1 (described below under in sub-
section 2.04.6)   
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IRF4IAD1 and IRF5IAD: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 The rmsd between the Cα atoms of IRF4IAD1 (182 residues) and IAD of IRF5 (auto-
inhibitory region was removed for the superimposition, 199 residues) is 1.13Å (Figure 15).  
Figure 15.  Superposition of IRF5IAD and IRF4IAD1 
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Similar to IRF3IAD, the IAD of IRF5 also has a more structured loop that corresponds to 
Loop Lβ9-β10 of IRF4IAD1, which is critical for interaction with a phosphorylated partner 
protein PU.1 (rmsd of 8.21Å and 7.22Å between subunit A and subunit B and the 
corresponding 12 Cα atoms in IRF5, respectively). Furthermore, the helix in the 
constitutively active IAD of IRF5 is non-superimposable with the corresponding helix α1 
of IRF4IAD1. There is a 7.5Å rmsd between helix α1 of subunit A of IRF4IAD1 with the 
corresponding 10 Cα atoms of IRF5. Loop Lβ7-β8 shows an rmsd of only 3.33Å and 2.91Å 
between the subunit A and subunit B and the corresponding 10 Cα atoms of IRF5, which is 
in contrast to what is observed for IRF3. The loop is buried and is inaccessible in the 
functional dimer of IRF5. Additionally, there is also negligible sequence similarity 
between the auto-inhibitory elements of IAD of IRF4 (last 30 residues) and those of IRF5 
(last 36 residues) and there are no corresponding phosphorylation sites in IRF4IAD1 as 
compared to the several sites available for IRF5. Instead there are threonine residues at 
some of the serine phosphorylation sites for example, Threonine 421 corresponding to 
Serine 421 and Threonine 435 corresponding to Serine 436.    
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2.04.6 Surface electrostatics of IRF4IAD1:  
 A surface representation of IRF4IAD1 is shown in Figure 16.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 16.  Surface representation of IRF4IAD1 
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Although the overall structure of IRF4IAD1 is almost completely superimposable with the 
IADs of IRF3 and IRF5, the surface residues of IRF4IAD1 are quite different than the 
other IADs. This is seen in Figure 17 showing the different views of the various IADs. In 
panel a of Figure 17, three different views of the surface electrostatics of IRF4IAD1 is 
shown. The original view of IRF4IAD1 is shown in inset. Encircled in yellow is the loop 
Lβ9-β10 with K399 shown previously to be important in interaction with phoshorylated PU.1 
As can be seen the region is highly positively charged and may explain its functional 
significance in making electrostatic interactions with negatively charged phosphate group 
in PU.1.  
 The different views of surface electrostatics of IRF5 IAD and IRF3 IAD are shown in 
Panel b and c of Figure 17, respectively. As pointed earlier the region corresponding to 
loop Lβ9-β10 of IRF4IAD1 has some helical character in either IADs and may not be 
suitable for interacting with a binding partner. In addition, in an auto-inhibited state in IAD 
of IRF3 (and IAD of IRF5), the loop corresponding to loop Lβ9-β10 of IRF4IAD1 (pointed 
by an arrow in inset in Panel a) is oriented such that it may impede interaction with any 
incoming partnering protein.  Further, in the activated state IRF5 (and IRF3 IAD) functions 
as a dimer and loop Lβ9-β10 is buried at the dimer interface. Also, worth noting is the 
apparent bulkiness of IRF5IAD as compared to IRF4IAD.  
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Figure 17. Surface electrostatics in three different views of IADs of IRF4, IRF5, IRF3 a. 
IRF4IAD1 b. IRF5IAD 
a.  
b.   
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 Also, encircled in black in Panel A is the region that forms the helix bundle in IRF4IAD1. 
The surface charge of helix bundles of IRF4IAD1, IAD of IRF5 and IRF3 are quite 
different. While the helix bundles of IRF5IAD and IRF3IAD are highly negatively 
charged, that of IRF4IAD1 is less charged and has some degree of hydrophobicity.   
 Several hydrophobic residues hold the helix bundle intact in IRF3IAD that buries the 
autoinhibitory elements including residues from helix α1, α3, α4 and additionally from α5. 
Figure 17. Surface electrostatics in three different views of c. IRF3IAD 
c.  
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Residues of α1, α3 and α4 are conserved between IRF3IAD and IRF4IAD1 including L247 
in α1, L413 in α4 and L365 and T361 in α4 of IRF4IAD1. Residues corresponding to 
V391, L393 and I395 in helix α5 of IRF3IAD are not found in IRF4IAD1 (see sequence 
alignment Figure 14) Leu329 in the helix α3 of IRF3IAD is conserved in all other 
members of IRF family. The corresponding residue in IRF4IAD1 is Leu368. Mutation of 
this residue to proline resulted in no ternary complex formation with phosphorylated PU.1 
(Meraro et al, 1999). The corresponding residues in IRF8IAD and IRF9IAD were also 
shown to be important in IFN signaling as well (Levi et al, 2002; Meraro et al, 1999). 
L368 is shown in red in Figure 18 along with some of other conserved hydrophobic 
residues that form the helix bundle. Since, this residue is conserved across all of the 
members of IRF family it may be critical in maintaining the helix bundle and protein-
protein interaction although most likely not being directly involved in the process. Since, 
IRF4IAD1 does not have the residues corresponding to the hydrophobic residues of helix 
α5 in IRF3 (see sequence alignment in Figure 14), L368 may be particularly the most 
critical residue in maintaining the helix bundle. Mutation of L368 may lead to loss in the 
integrity of the helix bundle and may affect the overall domain in its ability to form a 
ternary complex with phosphorylated PU.1.  
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2.02.7 Small angle X-ray scattering profiles (SAXS) of IRF4IAD1 and IRF4IAD2:  
SAXS data collection: 
 Samples for SAXS data collection were prepared by purifying them on a Superdex-75 
column pre-equilibrated in 25mM Tris-base pH 8.0, 500mM NaCl, 5mM BME, 10% 
glycerol right before data collection for both IRF4IAD1 and IRF4IAD2. Data were 
collected at the undulator-based beamline, X9 at National Synchrotron Light Source part of 
Brookhaven National Laboratory (Allaire and Yang, 2011). SAXS data were collected 
using a MAR165 CCD area detector, which was located at distance around 3.5m from the 
Figure 18. Helix bundle of IRF4IAD1.  L368 is shown in red along with L413, A417 
of α4 and A246 of α1 that make hydrophobic interactions in the bundle.  
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sample. The energy of the X-ray beam was ~ 2 keV. Additionally, X9 beamline is also 
equipped with a Photonic Science CCD detector useful to measure Wide Angle X-ray 
scattering (WAXS). Together, the two detectors allowed for data to be collected in the q 
range of 0.005 – 2.0 Å-1 where q = 4π sin (θ/2)/λ, θ is the scattering angle, and λ is the 
wavelength. The sample solution is run through a vacuum-sealed 1mm capillary 
eliminating background scattering.  
  Data was collected on for the IRF4IAD1 at three different concentrations of 1mg/mL, 
2.2mg/mL and 4.4mg/mL. Data was collected on for the IRF4IAD2 at two different 
concentrations of 0.8mg/mL and 0.9mg/mL. Each sample was exposed for 60 seconds and 
buffer subtraction was performed at the end of data collection.  
 
 
 
SAXS data processing: 
 Buffer subtraction and data processing is done using a Python-based packaged developed 
by the beamline scientist. The package allows users to convert 2D images into one-
dimensional SAXS profiles. WAXS data, which also part of the subtracted data is 
primarily used to study the crystallinity of polymers and was eliminated during further data 
processing. The buffer subtracted SAXS data were used for subsequent merging, trimming 
and model building. Merging, trimming and scaling were performed using PRIMUS 
including calculation of radius of gyration (Rg). GNOM was used to determine the P(r) 
distribution function to obtain Dmax for the molecule (Figure 19). SAXS parameters is 
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provided in Table 4. Subsequently, 10 ab initio models were built using both GASBOR 
and DAMMIN for IRF4IAD1 and IRF4IAD2. To build an averaged most typical model 
from these low-resolution ab initio models, DAMAVER suite of programs was used 
followed by a final run of DAMMIN to generate a final model of IRF4IAD1 and 
IRF4IAD2.  
SAXS parameters:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. SAXS parameters for IRF4IAD1 and IRF4IAD2 
Figure 19. P(r) distribution function of IRF4IAD1 
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Averaged IRF4IAD1 ab initio model: 
 
 The crystal structure of IRF4IAD1 was manually fit into the averaged SAXS molecular 
envelope in Pymol, a molecular visualization system (Figure 20) (Pymol) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. SAXS molecular envelope of IRF4IAD1 
(view 1)  
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Figure 20. SAXS molecular envelope of IRF4IAD1 
(view 2)  
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Comparison of the experimental and model scattering curves  
 
 Additionally to determine the accuracy of our SAXS model, we used a web-server (FoXS) 
(Schneidman-Duhovny et al, 2013), (Schneidman-Duhovny et al, 2010) to calculate a 
theoretical SAXS profile for the atomic resolution X-ray structure of IRF4IAD1 and 
compared its experimental SAXS profile.  We obtained a χ value of ~ 0.2 indicating an 
almost complete agreement between the theoretical and experimental SAXS profiles. This 
is also indicated below in a graphical representation.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Comparison of experimental and theoretical scattering profile of 
IRF4IAD1 
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Averaged IRF4IAD2 ab initio model 
 
 In order to determine the conformation of the AIR, we generated ab initio averaged model 
from the scattering data collected for IRF4IAD2. The Rg and Dmax values were slightly 
larger than IRF4IAD1 suggesting that this region will not be an unfolded loop (Table 4). 
We generated models of IRF4IAD2 with different conformations of the AIR and compared 
the experimental scattering profile with the one calculated for the different models. Two 
separate models were built – one using the X-ray structure of IRF4IAD1 as the template to 
generate Model 1 and another using the X-ray structure of IRF3IAD as a template to 
generate Model 2. The two models are shown in Figure 22. Models were built using the 
Modeller interface of Chimera (Sali and Blundell, 1993). Note the orientation and position 
of the last 30 residues (highlighted in red in each model) (Figure 22). In model 1 the last 30 
residues are more extended while in model 2 those residues are folded back on to the helix 
bundle similar to helix α5 of IRF3IAD. We used these individual models as an input pdb in 
BILBOMD (Pelikan et al, 2009), a web server allowing molecular dynamics based 
conformational sampling with integrated structure validation using FoXS to generate 
Minimum Ensemble Search (MES) models. The experimental scattering profile of 
IRF4IAD2 was used for structure validation.  
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 The MES model generated using Model 1 as an input pdb in BILBOMD best fit the 
experimental data shown in Figure 23. The chi value (χ) for the fit was 0.32. The MES 
model was manually fit into the averaged ab intio model in Pymol shown in Figure 24. 
 
 .  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. The two models used as an input for BILBOMD. Note the different 
orientation of the last 30 residues shown in red.  
 
Model 1 Model 2 
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Figure 23. Comparison of experimental scattering profile of IRF4IAD1 compared 
to the theoretical scattering profile generated for Model 1.  
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Figure 24. Two different views of manual fitting of MES model obtained from 
BILBOMD using Model 1 fit into the SAXS molecular envelope.  
View 1 View 2 
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 The MES model generated using Model 2 as an input pdb in BILBOMD did not fit the 
experimental data well shown in Figure 25. The chi value (χ) for the fit was 0.69. This 
indicates that the C-terminal extension of IRF4IAD2 does not fold like its auto-inhibited 
counterpart of IRF3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.03 Discussion: 
Figure 25. Comparison of experimental scattering profile of IRF4IAD1 compared 
to the theoretical scattering profile generated for Model 2.  
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 Although, overall the IADs of IRF4, IRF3 and IRF5 are superimposable, the crystal 
structure of IRF4IAD1 has helped shed light on the unique features of IRF4. The N-
terminal helix α1 in IRF4IAD1 is quite flexible in spite of forming a helix bundle with 
helices α3 and α4. Surface electrostatics of the helix bundle of IRF4IAD1 shows that the 
bundle is not as charged as those of IRF3 and IRF5. Yet the hydrophobic residues that 
form the helix bundle are quite conserved except for the residues corresponding to helix α5 
of IRF3. L368 of helix α3 in IRF4IAD1 seems to be critical in maintaining the helix 
bundle in IRF4. Mutation of this residue results in a mutant incapable of forming the 
ternary complex with PU.1 and DNA (Meraro et al, 1999). Disruption of the helix bundle 
may be the reason for the inability of IRF4 to form the ternary complex though direct 
interaction between L368 and PU.1 is highly unlikely. In addition, K399 in loop Lβ9-β10 sits 
in a pocket of highly positively charged residues. The residue is critical in formation of the 
ternary complex with phosphorylated PU.1 (Brass et al, 1999). The pocket may be 
involved in making electrostatic interactions with the negatively charged phosphate of 
PU.1.  
 SAXS molecular envelope of IRF4IAD2 suggests that the residues forming the AIR are 
structured. Yet their position is most likely not similar to helix α5 of IRF3IAD, which 
folds back onto the helix bundle and buries the auto-inhibitory elements. Based on our 
SAXS molecular envelopes, AIR seems to be positioned away from the helix bundle and 
towards the center of the full-length IRF4 making interactions with regions of the putative 
linker.  
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Chapter 3 
SAXS solution structure of full length IRF4 and the role of AIR in the activation process 
 
3.01 Introduction:  
 Transcription factors are multi-domain proteins with each domain having specific 
functions in the gene regulation process. Multi-domain proteins can have increased 
stability and also can have specific cooperative functions. Knowledge of the 3D structures 
of individual domains although valuable presents only small part of the story pertaining to 
the regulatory mechanism. For example, in the case of human nuclear hormone receptor 
structural studies were performed on the isolated DNA and ligand-binding domains but the 
cooperative interactions between the domains that modulates the properties of the full-
length receptor was not demonstrated until the structure of the full length peroxisome 
proliferator-activated receptor (PPAR-γ) in complex with retinoid X-receptor (RXR-α) was 
solved by Chandra et al (Chandra et al, 2008). The crystal structure of the complex 
provided information about missing extensions in the two proteins for example in the C-
terminus of RXR-α, which the authors suggest, is critical to RXR-α in forming heteromeric 
complexes with different binding partners. Human mitochondrial transcription factor A 
(TFAM) is another example of a multi-domain transcription factor where a flexible linker 
connects two high-mobility group (HMG) protein domains which becomes structured and 
is involved in interaction with DNA once bound to the ligand mitochondrial light strand 
promoter (LSP) DNA (Rubio-Cosials et al, 2011).  
  76 
 In case of IRF family of proteins, the crystal structure of individual DNA binding domains 
(DBD) and interferon activation domains (IAD) are available for several members of the 
family. But structural information of full-length proteins is lacking and hence, there is a 
void in the understanding of the characteristic regulatory mechanism. In case of IRF3 and 
IRF5, structural information about the interferon activation domain in its auto-inhibited 
and phosphorylation induced activated state respectively, described major conformational 
changes occurring upon phosphorylation  (Qin et al, 2003), (Chen et al, 2008). Although 
the structures of the full-length proteins were unavailable phosphorylation induced 
dimerization presented to be a viable mode of activation. 
 In case of IRF4, the proposed and currently accepted mechanism involves huge 
conformational changes in the full-length protein wherein the DBD and IAD pivot around 
a flexible putative linker (Brass et al, 1999). The authors suggested that the auto-inhibitory 
region (AIR) in the full-length protein physically impedes the DBD to generate a closed 
more globular state.  Although, structural information is available for IRF4 DBD 
(Escalante et al, 2002) and IAD (Chapter 1), even low-resolution structural information 
about how these domains are arranged in the full length of protein is unavailable. This lack 
of information limits a full mechanistic understanding of activation of IRF4. Secondary 
structure predictions of the putative linker region suggest the region to be unstructured but 
this could primarily be a result of lack of availability of any structural information of the 
region. It is worth pointing out here again that the AIR at the C-terminal of IRF4 was 
proposed to keep the full-length protein in the closed state. Furthermore, the protein was 
proposed to undergo huge conformational changes in the presence of its binding partner 
  77 
going between an ‘open’ more extended state in the activated form and a ‘closed’ more 
globular state (Figure 1).  Biophysical techniques like analytical ultracentrifugation (AUC) 
as well as small angle X-ray scattering (SAXS) provide excellent methods to access such 
conformational changes if present.  
 
 
 
 
 
 
 
 
 
  
 
 
  Sequence alignment of different members of IRF family of proteins (like IRF3, 5 &7) 
reveals that IRF4 is the only member with an N-terminal 20 amino acid extension (Figure 
Figure 1. Cartoon representation of full-length IRF4 in open & closed state. According to 
the currently accepted mechanism such conformational changes may occur during the 
activation process.  
Open state Closed state 
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2). 
 
 
 
 
 We cloned, expressed and purified full-length IRF4 protein with and without the first 20 
and/or last 30 residues (Figure 3). We performed AUC and SAXS studies on individual 
proteins to obtain the overall shape and size of the different IRF4 constructs to evaluate the 
conformation of the protein. We also performed flurorescence anisotropy binding 
experiments to determine the effect of the N-terminus and C-terminus extensions on the 
dissociation constants (Kd) of the four different constructs. We performed these 
experiments with a 21bp DNA with the ISRE IRF4 binding site adjacent to the PU.1 
binding site. The Kd determined here also aided in explaining the role of the N-terminal 20 
amino acid residues & the AIR in the gene activation process.   
 
 
 
 
 
Figure 2. Sequence alignment of the N-terminal 74 residues of IRF4 with IRF3, IRF5 and 
IRF7 is shown here. The first 20 amino acids of IRF4 are encircled in blue.    
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 3.02 Results:  
3.02.1 Purification of the different constructs: 
IRF4wt: 
Mouse full-length IRF4 construct 1-450 (IRF4wt) was subcloned into pET-15b TEV using 
the appropriate primers by a procedure similar to that mentioned in the results section of 
chapter 2 in purification of IRF4IAD1. Positive clones of IRF4w were transformed into 
BL21-pLysS* E. coli expression cells and an overnight pre-culture were grown using the 
appropriate antibiotics stress. IRF4wt was grown at 370C until the OD reached ~0.6, 
induced with 0.5mM IPTG & harvested after 6hrs. The cells were flash-frozen, thawed & 
resuspended in 25mM Tris-base pH 8.0, 500mM NaCl, 2mM TCEP, 5mM imidazole, 10% 
IRF4wt 
 
 
 
IRF4ΔC 
 
 
IRF4ΔN 
 
 
IRF4ΔNC 
 
 
Figure 3.  Schematic representation of the four different constructs of IRF4. (IRF4wt, 
IRF4ΔC, IRF4ΔN and IRF4ΔNC)  
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glycerol, sonicated and centrifuged at 20000 rpm for 30 mins. Protein was eluted from a 
Ni-NTA column with 300mM Imidazole and the Histidine (His) tag was removed using 
the home grown and purified Tobacco Etch Virus (TEV)-protease. The cleaved protein 
was further purified on Ni-NTA column to remove the His-tag as well as the TEV-
protease. Further purification of the cleaved protein was done using a phenyl sepharose 
with 25mM Tris-base pH 8.0, 1M NaCl, 1mM TCEP, 1mM EDTA as the binding buffer 
and a similar buffer with 25mM NaCl as the elution buffer. The last polishing step of the 
purification was done with gel filtration on a Superdex-75 column in 25mM Tris-base pH 
8.0, 300mM NaCl, 2mM TCEP & 5% glycerol. The protein was concentrated to about 
10mg/mL (0.196mM) & stored at -800 C in 100µL aliquots.  
 IRF4ΔC, IRF4ΔN and IRF4ΔNC were cloned, expressed and purified using a similar 
protocol described above. Yield of ~4-5mg of protein was obtained per litre of the culture 
for each construct.  
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Figure 4. SDS-page gel electrophoresis results for the purification of IRF4wt a. Ni-NTA 
column purification b. TEV-protease cleavage c. Second nickel column purification 
a. b
.. 
c.
c. 
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Figure 4. SDS-page gel electrophoresis results for the purification of IRF4wt d. Phenyl 
Sepharose column purification e. Gel purification  
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3.02.2 Analytical Ultracentrifugation studies: 
 We performed analytical ultracentrifugation studies on the four different constructs to 
assess their state of oligomerization if any and to detect any conformational changes 
between the different constructs. Sedimentation velocity profiles of the different IRF4 constructs 
are shown in Figure 5. Experimental and theoretical sedimentation coefficients of sphere of equal 
mass are shown in Table 1.  
 
Figure 5. Sedimentation velocity profiles of the different IRF4 constructs. The profiles 
are overlaid to compare their sedimentation coefficients. Total area under each cover is 
comparable. IRF4wt and IRF4ΔC may have slight oligomerization, which is in fast 
equilibrium.  
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 The sedimentation coefficients for the various constructs show that the open-closed model 
of activation for IRF4 is incorrect. The removal of AIR in IRF4ΔC does not result in 
drastic changes in the sedimentation coefficient. It is also worth noting that the proteins 
appear to be elongated (compare the Sw,20 of a sphere of equal mass with the experimental 
Sw,20).   
 3.02.3 Fluorescence anisotropy experiments:  
 To understand the role of the N-terminal 20 amino acid residues and the AIR in the gene 
activation process mediated by IRF4 we performed fluorescence anisotropy binding 
experiments titrating each of the different constructs against a constant concentration of a 
21bp 5’-fluorescein labeled DNA (F-DNA) (5’- /21-FAM/ TAT TTT CCT TCA CTT 
TGG TTT-3’). Excitation maxima of 498nm & emission maxima of 526nm were used for 
the experiment corresponding to the values reported for fluorescein tag. The fluorescence 
Table 1. Experimental and theoretical sedimentation coefficients of individual 
constructs and sphere of equal mas. Sw,20, corrected for water at 200C. Theoretical 
Sw,20, is calculated for a sphere of equal mass.   
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saturation curves of fraction of protein bound to the 21bp F-DNA (Y) against increasing 
concentration of protein (X) is represented in Figure 6 for individual constructs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Fluorescence saturation curve for the different constructs a. 
Fluorescence saturation curve for IRF4wt  
a. IRF4wt  
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Figure 6. Fluorescence saturation curve for the different constructs  
c. Fluorescence saturation curve for IRF4ΔN  
c. IRF4ΔN 
Figure 6. Fluorescence saturation curve for the different 
constructs b. Fluorescence saturation curve for IRF4ΔC  
b. IRF4ΔC 
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 The dissociation constants (Kd) for individual constructs calculated using the one site 
binding equation  
Y = Bmax*X/(Kd + X) 
 
are reported in Table 4. Bmax here is the maximal specific binding and the dissociation 
constant is a ratio of koff/kon (koff – off rate of binding and kon –on rate of binding) for a 
protein-ligand binding event in equilibrium. Dissociation constants for the different constructs 
are shown in Table 2. 
 
 
 
Figure 6. Fluorescence saturation curve for the different 
constructs  d. Fluorescence saturation curve for IRF4ΔNC  
c. IRF4ΔNC 
Table 2. Dissociation constants for the different constructs. 
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 Surprisingly, we found that the removal of the N-terminal 20 amino acids residues results 
in a substantial improvement in the ability of the protein to bind the 21bp F-DNA indicated 
by a marked decrease in Kd. Removal of the AIR does not result in any appreciable change 
in Kd. This result is in direct contrast of what would be expected if the currently accepted 
model of the activation process were accurate. The mechanism was proposed based on gel-
shift assays performed on truncated proteins. Using the crystal structure of IRF4IAD1 as a 
guide, we assessed the constructs that were used for the gel-shift assays and have 
concluded that for structural integrity of the truncated proteins where AIR was removed 
were not intact and the results obtained in the gel-shift assays may be erroneous.  
 
 
3.02.4 SAXS studies: 
Protein Dissociation constant (Kd) 
IRF4wt 1.27µM 
IRF4ΔC 1.25µM 
IRF4ΔN 138nM 
IRF4ΔNC 129nM 
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 SAXS curves for each of the four constructs are depicted in Figure 7. SAXS profile for 
each construct was analyzed for possibility of aggregation in the sample, which is 
indicated by an upward turn in the low q region of a scattering profile (region encircled in 
the scattering profile of IRF4wt in Figure 7 a.). None of the samples showed any signs of 
aggregation & thus, further analysis of each sample could be carried out successfully.  
 
 
 
 
 
 
 
 
Figure 7. SAXS scattering profile for different constructs a. SAXS 
scattering profile for IRF4wt. Note that there is no sign of aggregation in 
the low q region encircled in black.   
a. 
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Figure 7. SAXS scattering profile for different constructs b. SAXS 
scattering profile for IRF4ΔC.  
b.
 
Figure 7. SAXS scattering profile for different constructs  c. 
SAXS scattering profile for IRF4ΔN.  
c. 
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 Plots for pair-distribution function (P(r) function) are presented in Figure 8.  The P(r) 
distribution function is used to calculate the maximum length of the scattering molecule. 
P(r) distribution function of each of the four constructs have been overlaid here for 
comparing the difference in Dmax between the different constructs.  
 
 
 
 
Figure 7. SAXS scattering profile for different constructs d. SAXS scattering 
profile for IRF4ΔNC.  
d. 
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 Kratky plots useful in determining the extent of unfoldeness in proteins were also plotted 
and were helpful in comparing the extent of flexibility between the different constructs 
(Figure 9).  
 
 
Figure 8. P(r)- distribution function for the different constructs overlaid for 
comparison.  
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 The basic structural parameters that describe the individual constructs; radius of gyration 
(Rg), maximal dimension (Dmax) and Porod exponent are tabulated in Table 3.   
 
 
 
Figure 9. Kratky plots for the different constructs overlaid for comparison.  
Table 3. Rg, Dmax and Porod exponent of the different constructs  
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 Based on the P(r) distribution functions, the corresponding Dmax and the Kratly plot, we 
conclude that IRF4wt is present in an extended conformation in the DNA unbound state and 
not in a globular conformation as would be expected if the currently accepted model were 
true. Furthermore, we do not observe any large conformational changes in the SAXS 
profiles and associated parameters of the different constructs. An increase in Porod 
exponent from 2.2 for IRF4wt to 3.2 for IRF4ΔNC is indicative of systematic decrease in 
flexibility between the proteins.   
 The molecular shape for individual constructs was determined using the programs 
available in ATSAS software suite for ab-initio reconstruction (ATSAS). Using the 
GNOM (Svergun, 1992) output file, which specifies the Dmax for the protein, ten models 
were generated in two different ab-initio reconstruction programs, DAMMIN (Svergun, 
1992) and GASBOR (Svergun et al, 2001) for each construct individually. Each set of the 
ten models from DAMMIN and GASBOR were averaged separately using SUPCOMB 
(Svergun, 2001). The averaged model for each construct from either of the two programs 
was run through DAMMIN one last time using the averaged model as the input pdb to be 
fit into the SAXS profile (.dat file). Normalized spatial discrepancy (NSD) parameters 
were calculated (reported in Table 4.) to compare the models generated from either of the 
two programs for each construct and increased our confidence in the models.  
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We used the experimental sedimentation co-efficient values generated by the AUC studies 
as a parameter to increase our confidence in the ab-initio models. We used US-SOMO (Rai 
et al, 2005), (Brookes et al, 2010b), (Brookes et al, 2010a) in Ultrascan III software to 
calculate a theoretical sedimentation co-efficient for the final averaged bead models 
generated from either DAMMIN or GASBOR for the individual constructs. These were 
compared to the experimental sedimentation coefficients obtained for the different 
constructs (Table 5).  
 
 
 
Table 4. , NSD comparing the averaged Gasbor and Dammin models of the different 
constructs. (NSD of less than one is indicative of a good correlation between the different 
models being compared 
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We observed a good correlation between the theoretical S-value calculated based on the 
SAXS ab-intio model and the experimental S-values for the individual constructs (The 
partial specific volume of the protein & the viscosity of the buffer were corrected for 
before calculating the S-values) Table 5.  
 Superimposition of IRF4wt on IRF4ΔNC is shown below in Figure 10a. It can be seen that 
there are no significant differences between the overall shape when both the N- and the C-
termini of the protein are removed. Interestingly, IRF4ΔC shows the presence of a broad 
density (encircled in red) that is absent in both IRF4ΔN and IRF4ΔNC (Figure 10 b and c). 
This region may correspond to the N-terminal 20 residues in the absence of the AIR 
indicating that there may be some indirect interaction between the N- & the C-terminal 
residues presumably through the linker that is lost when the AIR is removed. 
Table 5. Experimental and theoretical sedimentation coefficients of individual constructs and 
calculated for Gasbor models. Sw,20, corrected for water at 200C. Theoretical Sw,20 were 
calculated for the SAXS envelopes obtained from Gasbor 
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Figure 10. SAXS molecular envelope 
of individual constructs a. 
Superimposition of IRF4wt (green) on 
IRF4ΔNC (white). b. 
Superimposition of IRF4ΔC (yellow) 
on IRF4ΔNC (white) c. 
Superimposition of IRF4ΔN (blue) on 
IRF4ΔC (yellow)  
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  We used the program CORAL (Petoukhov, 2012) to perform rigid body modeling to fit 
the individual DBD and IAD against the SAXS profile and into the ab-intio model 
generated for IRF4ΔNC. The two domains were manually moved into the SAXS molecular 
envelope of IRF4ΔNC until there was visual satisfaction of the fit. Next we fixed the initial 
coordinates of the individual domains fit through visual inspection for a run of CORAL to 
generate Model 1 (Figure 12). We also ran CORAL by not fixing the initial coordinates of 
the individual domains to generate Model 2.  The loops utilized for fitting the putative 
linker connecting the two domains linker are chosen from a pre-defined library of loops. 
Finally, simulated annealing is utilized to find the optimal orientations of the atomic 
structures and approximate conformations of loops (Figure 11).  
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Figure 11. Flow chart representing the protocol used to generate models in CORAL  
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 The most probable orientation of the two domains, DBD & IAD is likely to be in-between 
the two representative models presented in Figure 12.  In Model 1 there are minimal 
clashes between the N- & the C- terminal domains and the putative linker and the Rg of 
model 2 of 30Å is close to the experimental Rg of 36Å.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Two distinct models generated using CORAL  
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 The individual models (Model 1 & Model 2) were fit into the SAXS molecular envelope 
of IRF4ΔNC using the program Supcomb (Svergun, 2001). The fit is shown in Figure 13. 
Model 1 fits into the envelope better we calculated an NSD of 1.167 between model 1 & 
the envelope. We obtained a slightly higher NSD of 1.259 between Model 2 & the SAXS 
envelope. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model 1 fit into SAXS 
envelope 
Model 2 fit into SAXS 
envelope 
Figure 13. Supcomb based fitting of the two different models 
generated from CORAL into the SAXS envelope of IRF4ΔNC 
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 The two domains are most likely located at the either ends of IRF4ΔNC suggested by the 
two models generated using CORAL. This can be extrapolated to IRF4wt since the two 
proteins do not differ considerably in their overall shapes. In addition, the model also 
suggests the orientation of the DBD & IAD as facing the centre of IRF4ΔNC. This may 
also be fairly accurate since the different constructs do not show long extensions on either 
ends. Interestingly, docking of the DBD & IAD into the SAXS molecular envelope of 
IRF4ΔNC suggests that the putative linker that joins the N-terminal DBD with the C-
terminal IAD must be folded. The physical space between the DBD & IAD as well as the 
Rg and Dmax of IRF4ΔNC reinforce this observation. Nevertheless, it does not rule out the 
possibility that the region has some degree of flexibility yet there appears to be an overall 
domain characteristic to the region. The region may not be an independently folding 
domain & seems to require the DBD & IAD to maintain it in the folded state. This was 
suggested by our inability to successfully express & purify the constructs with the DBD 
and different lengths of the putative linker (see Results section of Chapter 4).  
As pointed before we did not observe conformational changes corresponding to distinct 
open & closed states between the different constructs. An average NSD of 0.688 was 
calculated comparing the SAXS molecular envelopes of the four constructs further 
suggesting the envelopes have subtle and not extensive changes in structure.  
  
3.03 Discussion:  
 The currently accepted model of gene regulation by IRF4 lacks any support from 
structural studies performed on the full-length protein. Based on the low-resolution SAXS 
  103 
models as well as the analytical ultracentrifugation studies presented here it is clear that the 
protein does not undergo huge conformational changes when AIR is removed and is 
present in solution in an extended conformation in the DNA unbound state. Furthermore, 
although the putative linker may have some flexibility to it, based on our SAXS models the 
region appears more structured than previously reported and may be rechristened as a 
‘novel’ domain.   
  To understand the inhibitory mechanism of the N-terminal extension on binding, we 
superimposed the crystal structure of DBD of IRF4 on the solution NMR structure (2DLL) 
of the DBD (Figure 14). 
 The region is unstructured and may physically impede the IRF4DBD from binding to the 
21bp DNA. In other words, the flexible N-terminal residues may decrease the binding 
affinity of full-length IRF4. Thus, although IRF4wt may bind DNA, the protein-DNA 
complex may not be stable. It is worth noting that IRF4 is the only member of the IRF 
family that has this N-terminal extension. Furthermore, IRF4 along with IRF8 are the only 
members that have a high degree of promiscuity with respect to their binding partners. 
Also, the crystal structure of the ternary complex between IRF4/PU.1/21bpDNA pointed to 
the cooperativity between the two proteins through residues V111, L116 and D117 in 
IRF4DBD and R222 and K223 in PU.1DBD. Hence, the cooperativity between IRF4 and  
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its binding partner may play a role in stabilizing the binding of IRF4wt to DNA and may 
explain the need for a binding partner for IRF4 in its regulatory mechanism.      
 Interestingly, when the SAXS molecular envelope of IRF4ΔNC is integrated with the 
crystal structure of the ternary complex of DBD of PU.1, IRF4 and DNA it becomes 
obvious that the additional interaction between PU.1 and IRF4 would require 
conformational changes in both the proteins to successfully regulate transcription. The 
crystal structure of the ternary complex between PU.1, IRF4 and DNA will surely provide 
further insight into the mechanism of regulation. 
Figure 14.  Superposition of crystal structure of IRF4 DBD on its NMR structure. 
Flexible N-terminus loop is shown in red 
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Chapter 4  
Structural details of the putative linker of IRF4 
 
4.01 Introduction:  
 Spacers of short amino acid sequences, frequently called linkers are generally thought to 
primarily to separate domains in multi-domain proteins. However, the most important role 
of linkers is to ensure that undesirable interactions between the individual domains are 
prevented. Thus, linkers may have some degree of rigidity conferred to them (George and 
Heringa, 2002; Reddy Chichili et al, 2013). Length of linkers can range from 3-40 amino 
acids. The length of the linkers is also critical & has been shown to affect protein stability 
and domain orientations (van Leeuwen et al, 1997; Robinson and Sauer, 1998). For 
example, decreasing the length of the linker connecting the sub-domains of phosphorylated 
smooth-muscle myosin leads to cessation of actin translocation activity (Ikebe et al, 1998). 
The conformational activation of α1 intergrins is another example where the length of the 
linker is shown to be critical (Weitz-Schmidt et al, 2011). The C-terminal (C-linker) 
connects the α domain to the β domain forming the α/β heterodimeric integrins. The length 
of the C-linker was demonstrated to be critical in maintaining negative regulation of the α 
domain by the βI domain. Linkers are also important in maintaining cooperative 
interactions between domain (George and Heringa, 2002). For example, it was shown for 
Src family of kinases that mutation of a critical residue (Trp260Ala) in the linker leads to 
uncoupling of the catalytic and regulatory domains ((LaFevre-Bernt et al, 1998), (Briggs 
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and Smithgall, 1999)). The coupling ensures that the catalytic activity of the protein is 
repressed. Linkers may also serve as regions that directly interact with a ligand and provide 
additional binding energy to ensure robust binding of the ligand. For instance, the structure 
of human PAX6 PD (paired DNA binding domain) DNA complex showed that the glycine 
rich linker of human PAX6 makes minor groove interaction with the DNA ((Mishra et al, 
2002; Xu et al, 1999). More recently, linkers have been documented to be involved in 
oligomerization events of specific proteins. In case of hsp70, Aprile et al (Aprile et al, 
2013) showed that oligomerization of hsp70 involves specific interaction between the 
interdomain linker of one molecule of hsp70 with substrate-binding domain of another 
molecule of hsp70. Another instance of linker-mediated oligomerization is shown for 
Rep68 structural protein of Adeno Associated Virus-2 (AAV-2). Herein, an aromatic 
amino acid, Tyrosine224 was shown to be critical in ensuring oligomerization and 
infectivity of AAV-2 virus (Zarate-Perez et al, 2012).  
  Linkers may be broadly classified into two categories - helical and non-helical (George 
and Heringa, 2002). Helical linkers are often poly-glycine linkers and are often also 
referred to as soft peptide linkers (Wriggers et al, 2005). These linkers have been 
frequently used in protein engineering experiments to fuse two domains to allow for some 
degree of flexibility conferred to the fusion proteins. Non-helical linkers or often also 
called ‘molecular rulers’ are frequently poly-proline linkers. They have been referred to as 
molecular rulers because these hard linkers may be used to predict end-to-end distances 
and hence depths of binding pockets. Interestingly, proline residues are found to be the 
terminal residues in linking different domains. This may be because of the inability of 
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proline to form any regular secondary structure and thus ensure rigid separation of 
domains. The trans conformation of proline residues maintains rigidity while neighbor 
dependent change in conformation of proline residue from trans to cis confers flexibility to 
these linkers. Other residues that are frequently found in linker regions glutamine, arginine, 
glutamate, and serine (Wootton and Drummond, 1989).   
 In IRF4, the putative linker is much longer, composed of 100 residues. It has about 17% 
of proline residues, which would categorize it as a non-helical linker. Hence, the putative 
linker is also expected to have high rigidity and may lack any appreciable secondary 
structure. Previously accepted mechanism for IRF4 activation suggested the linker to be 
highly flexible. Intriguingly, there is also a report suggesting post-translational regulation 
of IRF4 wherein peptidyl-prolyl isomerase was shown to catalyze the trans to cis 
isomerization of proline residues in the putative linker region (Mamane et al, 2000). The 
isomerization may render some flexibility to the linker. The results obtained from the 
SAXS studies of full-length IRF4 that suggested the possibility of a structured linker, thus 
we used X-ray crystallography and SAXS studies to characterize the linker region.  
 We performed crystallization trials of IRF4ΔNC with a 17bp DNA, which later proved to 
be crystals of the degradation product of IRF4ΔNC. We also attempted to express and 
purify various different constructs of IRF4 with the DNA binding domain and different 
regions of the linker. SAXS scattering profile of IRF420-201 & IRF4202-450 showed 
aggregation of the sample and further analysis of the sample to generate ab-initio SAXS 
molecular envelopes was not carried out.  
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4.02 Results:   
4.02.1 Crystallization of full-length IRF4 with a 17bp-DNA: 
 Crystallization of full-length IRF4 was attempted using two constructs IRF4ΔN (20-450) 
and IRF4ΔNC (20-420). Crystallization trials were performed simultaneously in the 
presence and absence of DNA. Different lengths of DNA from 17-21bp were utilized for 
the trials. In addition to a wealth of information provided by a crystal structure of full-
length IRF4 in presence of DNA, the DNA as a ligand can minimizes the different 
probable conformations of the full-length protein and makes the protein more favorable for 
hits in crystallization trials. The two different constructs were mixed with the individual 
DNAs in molar ratio of 1:1.2 (protein:DNA) and concentrated upto ~16-20mg/mL (350-
430µM of protein concentration). Hanging drop crystallization trials were performed with 
the available factorial screens from Hampton and Emerald Biosciences at 200C. 
Microscopic needle shaped clustered crystals were obtained in Emerald Biosciences 
condition 0.1M MES pH6.5, 12% PEG 20K for the protein complex with a 17bp DNA (5’-
AAG GAA GTG AAA CCA GG -3’) (Figure 1). The condition showed high degree of 
precipitation and phase-separation and the crystals appeared from the precipitated drops in 
about 5-7 days. An optimized condition of a slightly higher percentage of 15% PEG20K in 
0.1M MES pH 6.0 showed slight improvement in the appearance of the crystals. These 
bunches of crystals were sent to Argonne National Laboratory GM/CA beamline, which is 
equipped with a microfocus beam that can be utilized to collect data on microcrystals. 
Some of the crystals diffracted to about 5Å and the diffraction pattern indicated that the 
crystals were of protein and/or protein-DNA complex and not of salt.  
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Figure 1.  Cluster of crystals of IRF4ΔNC with 17bp DNA  
and diffraction pattern a. Cluster of crystals of IRF4ΔNC with 17bp DNA b. Image 
of the single crystals being shot using a micofocus beam at Argonne National 
laboratory (Illinois) c. A representative diffraction image showing few spots   
a
. 
b. 
c. 
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To increase the size of the crystals and to obtain single crystals, an additive screen was 
performed around the optimized condition. 40-80mM cesium chloride dramatically 
improved the crystals and resulted in single crystals measuring about 100 microns (Figure 
2). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2.  Single crystals of IRF4ΔNC with 17bp DNA  
and diffraction pattern a. Single crystals of IRF4ΔNC with 17bp DNA b. A 
representative diffraction image.    
b. 
a
. 
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The crystals diffracted to ~ 2.9Å and could be indexed with a P222 spacegroup. The 
crystals were still considerably small and a complete data set could not be collected. The 
data set was collected at the X25 beamline at NSLS. The data collection statistics are 
provided in Table 1. 
 
Data collection IRF4ΔNC / 17bp DNA 
Space group P222 
Cell dimensions    
    a, b, c (Å) 39.1, 41.3, 114.8 
    a, b, g  (º) 90  90  90  
Resolution (Å) 2.9 
Rmerge 6.8 (13.6) 
I/σI 13.5 (5.4) 
Completeness (%) 48.75 (13.3) 
 
 
 
 
  
 
Table 1.  Data collection statistics of IRF4ΔNC with 17bp DNA. Completeness for 
the data set was lower than 50% 
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 Surprisingly, the unit cell parameters of the crystals were smaller than would be expected 
for IRF4ΔNC of molecular weight ~46kDa. We investigated whether the crystals were of a 
degradation product of IRF4ΔNC. An SDS-page gel indicated that the crystals were indeed 
degraded products of IRF4ΔNC and the molecular weight of the degradation product was 
~28kDa. Using the molecular weight of the degradation product as a parameter, we next 
investigated whether the crystals were of the N-terminal DBD domain plus some region of 
the putative linker (NTD) or of the C-terminal IAD (both have a molecular weight 
~28kDA). Western blot of the crystals using a primary antibody against the N-terminal 
DBD confirmed that the degraded product contained the N-terminal DBD along with some 
region of the putative linker.  
 
 
 
 
 
 
 
 
 
 
 
 We will further try to improve the condition to be able to collect a better data set to 
determine the crystal structure of the putative linker. To this end, we designed several 
Figure 3. Western blot analysis of the crystals of IRF4ΔNC. The crystals 
were confirmed as having the DBD.  
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different constructs of DBD along with some additional residues from the linker. We 
aimed at expressing, purifying & crystallizing these constructs.  
4.02.2 Purification of protein constructs for additional crystallization attempts: 
  Expression of different protein constructs with IRF4DBD plus varying regions of the 
putative linker were attempted in BL21*pLysS cells. All the constructs IRF4 1-237, IRF4 
20-225, IRF4 20-231 and IRF4 20-237 did not yield more than 4mg/L of the culture after 
the first immobilized-metal affinity chromatography (Figure 4). IRF4 20-237 was further 
purified on a gel-filtration column although the purity of the protein did not improve 
(Figure 4. b.). About 500µg of total purified protein was obtained from 1L culture. Protein 
was detected in inclusion bodies for each of the constructs and change in induction 
temperature to 180C did not improve the yield in soluble fraction.  
 
 
 
 
 
 
 
 
 Figure 4. SDS-gel electrophoresis result of different constructs of IRF4  
with varying regions of the linker a. SDS-gel electrophoresis result of IRF4 1-
237 expressed in BL21*pLysS cells. Over expressed protein is seen in inclusion 
bodies (shown by arrow)  
  114 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. SDS-gel electrophoresis result of different constructs of IRF4  
with varying regions of the linker b. SDS-gel electrophoresis result of IRF4 20-237 
expressed in BL21*pLysS cells. Left panel shows the fractions obtained after 
purification on a Ni-NTA column & right panel shows the fractions obtained after 
purification gel filtration column 
 
Figure 4. SDS-gel electrophoresis result of different constructs of IRF4  
with varying regions of the linker c. SDS-gel electrophoresis result of IRF4 
20-231 expressed in BL21*pLysS cells. Over expressed protein is seen in 
inclusion bodies as well as very little protein is seen in soluble fraction 
(shown by arrow)  
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 Expression of IRF4 20-225 was attempted in BL21pLysS Codon plus cells (RIPL cells) 
with a slight increase in expression level (Figure 4. d). The protein was further purified 
after removing the His-tag on a gel filtration Superdex-75 column pre-equilibrated in 
25mM HEPES pH 7.5 150mM NaCl, 1mM TCEP. We obtained ~ 1mg/L of purified IRF4 
20-225 after the final gel filtration polishing step.   
 
 
 
 
 
 
 
 
 
 
Figure 4. SDS-gel electrophoresis result of different constructs of IRF4  
with varying regions of the linker d. SDS-gel electrophoresis result of IRF4 20-
225 expressed in BL21pLysS Codon plus cells. Over expressed protein is seen 
in inclusion bodies as well as very little protein is seen in soluble fraction 
(shown by arrow)  
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4.02.3 Thrombin fragments of IRF4ΔN: 
Using peptidecutter from Expasy, a pseudo-thrombin protease cleavage site was 
determined after residue 201 of IRF4wt. Since, we had little success with expression and 
purification of the above-mentioned constructs we attempted to obtain fragments of 
IRF4ΔN (IRF4 20-201 & IRF4 202-450), purify the protein & perform crystallization trials 
on the individual fragments separately.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Western blot analysis of thrombin proteolysis of IRF4ΔN. The fragment 
IRF4 20-201 showing the presence of the DBD of IRF4 is shown here (red arrow)   
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 We took advantage of this site and performed thrombin cleavage on IRF4ΔN purified to 
homogeneity as per the procedure previously described (Results section of Chapter 3). The 
protein was desalted into thrombin cleavage buffer (25mM Tris-base pH 8.0, 200mM 
NaCl, 10% glycerol) and thrombin was added at 1U per mg of protein and the cleavage 
reaction continued at room temperature for 4-6hrs. The reaction was stopped with protease 
inhibitor p-aminobenzamidine-agarose beads by continuous shaking for 45 mins. The two 
fragments were separated on a phenyl-sepharose column (Figure 6) followed by a final 
step of gel filtration into 25mM HEPES pH 7.5, 150mM NaCl, 1mM TCEP.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Purification of the fragments (IRF4 20-201 & IRF4 202-450) on 
a phenyl sepharose column. The two fragments separated as two peaks in 
the elution profile.  Uncut IRF4ΔN was separated from IRF4 202-450 on 
the gel filtration column)    
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4.02.4 SAXS studies of IRF4 20-201 & IRF4 202-450: 
 SAXS data were collected as previously mention in the results section of Chapter 3 though 
the Mail-in service at the Advanced Light source at Berkeley. Both IRF4 20-201 & IRF4 
202-450 were buffer exchanged into 25mM Tris-base pH 8.0, 300mM NaCl, 2mM TCEP, 
5% glycerol before shipping the samples for data collection. 
 The SAXS scattering profile of IRF4 20-201 showed an upward turn at low q range 
indicative of aggregation and was not processed any further (Figure 7).  
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
IRF4 20-201 
Figure 7. Scattering profile of IRF4 20-201. An upward turn is seen in the low q 
range (encircled in black)  
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The SAXS scattering profile of IRF4 202-450 also showed an upward turn at low q range 
indicative of aggregation and was not processed any further (Figure 8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 We will attempt to send these samples for SAXS data collection in different buffers with 
different salts as well as reducing agents.  
 
 
 
Figure 8. Scattering profile of IRF4 202-450. An upward turn is seen in the low q 
range (encircled in black)  
IRF4 202-450 
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Crystallization trials of IRF4 202-450: 
 Crystallization trials of IRF4 202-450 were attempted using the Gryphon crystallization 
robot. The protein could be readily concentrated to ~ 10mg/mL and factorial screens were 
set up using commercially available crystallization screens from Midwest Center for 
Structural Genomics. Most of the trays showed clear crystallization drops & no sign of any 
crystals  
 We reason that the concentration of the protein was in the under saturated portion of a 
crystallization phase diagram (Figure. 10). We will increase the protein concentration to 
~20mg/mL or even higher (limited only by visualization of precipitation) and retry 
crystallization of IRF4 202-450. At higher concentration the protein should enter the 
supersaturated and induce crystal formation.  
 
 4.03 Future directions: 
 Structural information about the putative linker is pivotal in understanding the activation 
of IRF4. Since we obtained diffracting crystals for IRF4ΔNC with 17bp DNA we will 
focus our efforts in getting a better data set even though we have shown that the crystals 
are of a degradation product of IRF4ΔNC. Further, since we have purified IRF4 20-225 
(construct with DBD along with some portion of the linker), we will perform fluorescence 
anisotropy with a 21bp F-DNA (composite site containing both IRF4 and PU.1 binding 
sites) to assess the effect of the linker on the DNA binding ability of IRF4. In addition, we 
will perform circular dichroism experiments on IRF4 202-450 to get secondary structure 
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information about the linker region and compare the results obtained with circular 
dichroism spectra of IRF4IAD1 & IRF4IAD2. We will also perform SAXS studies on 
IRF4 20-201 & IRF4 202-450 in different buffers. Crystallization trials will also be 
attempted for IRF4 20-201 with DNA as well as for IRF4 202-450.  
 Although, crystallization experiments can be quite challenging, the information obtained 
from circular dichroism and fluorescence anisotropy experiments proposed here we will be 
able to obtain a more complete picture of the putative linker and its role in the activation 
process of IRF4.     
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Conclusion and future directions 
  IRF4 is a unique member of the IRF family of transcription factors. It regulates 
transcription of various genes by forming ternary complexes with different transcription 
factors, presumably through its IAD. Our structural studies of IRF4IAD1 highlighted 
several salient features that make IRF4 unique in the IRF family. The N-terminal helix α1 - 
involved in forming a helix bundle - is quite flexible and may provide flexibility to the 
full-length protein. This helix bundle is stabilized by hydrophobic interactions of residues 
L413 from helix α4 and L368 from helix α3 with additional interactions provided by A246 
of helix α1. The surface electrostatics of IRF4IAD1, especially around the helix bundle is 
more hydrophobic than the helix bundles of IRF3 & IRF5. Lastly, we identified loop Lβ9-
β10 that accommodates K399 in a pocket of positively charged residues. The flexibility of 
this loop is a unique feature of IRF4IAD1 that may enable its interaction with 
phosphorylated PU.1. SAXS studies of IRF4IAD2 revealed that the AIR is most likely 
folded and probably interacts with a region in the linker region. If the AIR were interacting 
with the DBD as previously proposed, we would expect these residues to be unfolded & 
completely extended.  The AIR also lacks phosphorylation sites corresponding to those of 
IRF3 and IRF5 and the sequence alignment of this region is also quite low. Thus, the AIR 
appears to quite different in IRF4 and may provide additional exclusivity to IRF4 in its 
regulation process.   
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 Our fluorescence anisotropy binding studies identified the first 20 residues unique to IRF4 
and not the AIR to be important in decreasing the binding affinity of full-length IRF4 to 
DNA. These residues most likely impede the recognition helix from making specific 
hydrogen bond interactions with nucleic acid bases in the major groove of DNA. We show 
through analytical ultracentrifugation (AUC) studies of full-length IRF4 that the protein 
occurs as a single species in solution with a sedimentation coefficient of ~3.4S indicating 
that the protein is not globular but extended. Furthermore, our SAXS studies of the full-
length protein corroborate with this result and show no dramatic differences in the overall 
shape of the protein in the presence or absence of the AIR. SAXS studies also suggest hat 
the putative linker is most likely a folded domain. This result is in direct contrast to what it 
would be expected if the previously proposed mechanism of inactive-close and active-open 
states and conformational changes therein were accurate. Porod exponent obtained from 
our SAXS studies of IRF4wt of ~2.2 is indicative of appreciable degree of flexibility in the 
molecule. Removal of the N-terminal 20 residues or the AIR results in systematic decrease 
in the flexibility in IRF4 with an increase in Porod exponent to 3.3 for IRF4ΔNC. 
Moreover, there are subtle yet visually perceivable differences in the overall shape of IRF4 
in the presence and absence of the first 20 residues or the AIR.  
 Taken together, we have come up with a different mechanism of activation for IRF4 than 
what was previously suggested shown in the schematic below. We propose that full-length 
IRF4 occurs as an extended and a flexible molecule in solution, which can bind DNA 
There is no auto-inhibited closed state for the protein, but the N-terminal 20 residues of 
IRF4 decreases its binding affinity to DNA. The binding event is most likely transient and 
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hence not effective. Interaction of IRF4 with a partner protein like phosphorylated PU.1 
ensures stable complex formation and prevents IRF4 from falling off the DNA. Following 
the ternary complex formation transcriptional regulation of the effector gene ensues.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of the new proposed mechanism of activation 
of IRF4 
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 There are several questions that still remain unanswered about the process of activation of 
IRF4, for example: is the off rate of the binding event reduced during the complex 
formation? What is the sequence of binding events during the assembly of the ternary 
complex? A more rigorous examination of the ternary complex formation may be 
performed using Surface Plasmon Resonance (SPR) & Isothermal Calorimetric (ITC) 
techniques. More importantly, structural details of the putative linker region needs to be 
determined using a combination of biophysical techniques like AUC, SAXS & X-ray 
crystallography. Circular dichroism techniques may be used to gain some insight into the 
secondary structure of AIR as well as the putative linker. Furthermore, structural studies of 
full-length IRF4 in conjunction with its various binding partners, although challenging, 
seems like a viable future direction. It will provide molecular details of different surfaces 
of interaction between IRF4 & its binding partners. We could then understand the 
peculiarity of assembly of the hetero-complexes of IRF4 with its partner and in turn shed 
light on the promiscuity of this transcription factor.     
 A detailed mechanistic picture of the activation process of IRF4 may be exploited in 
designing therapeutic end products for diseases modulated by IRF4 like multiple myeloma, 
certain auto-immune disease and in cardiac hypertrophy.    
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Appendix 
A. X-ray crystallography:  
 X-ray crystallography is an experimental technique that employs X-rays of wavelength in 
Ångstrom scale (~10-10 m) such that atomic level information of the scattering protein 
molecules can be determined. X-ray crystallography utilizes crystals made of regularly 
spaced lattices of protein molecules. The electron clouds of individual atoms scatter the X-
rays and thus a diffraction pattern in obtained. The three-dimensional structure of the 
protein under investigation can be reconstructed using from the diffraction data and 
additional phase information.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic representation of diffraction of a crystal & the 
collected diffraction pattern. (Ugleingo, 2013) 
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A.01 X-ray crystallography basics:  
Unit cell: 
 A unit cell is the simplest repeating unit composed of all the structural and symmetry 
information to reproduce the crystal lattice by translation along the cell edge. 
 
Asymmetric unit: 
An asymmetric unit is the smallest unit composed of all the structural information to 
reproduce the unit cell by symmetry operations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Schematic representation of an asymmetric unit, a unit cell & 
their arrangement in a crystal. Image from (Shuchismita Dutta) 
  128 
 
Bravais lattices: 
 Translating the unit cell contents in 3-D creates lattice systems called the Bravais lattice 
system that are 14 in number (Figure 3). A combination of rotations and translations results 
in a distinct pattern of symmetry elements that form the space groups each of which 
belongs to a Bravais lattice system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Bravais lattice system (picture) 
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A.02Structure determination: 
 To determine the 3-D crystal structure of any protein information regarding the 
distribution of the electron density that is related to the atomic positions in the unit cells 
needs to be deciphered from the diffraction data.  The electronic density function is given 
by, 
ρ(x,y,z) = (1/V) Σhkl  Fhkl e -2πi(hx+ky+lz)+iφhkl 
where, Fhkl are structure factors (the quantity expressing both amplitude & φhkl  phase of the 
reflection corresponding to the diffracted beam in reciprocal space with indices hkl of real 
space (x,y,z) coordinates that represents atomic positions) and V is the cell volume. To 
solve for ρ(x,y,z) information about the amplitude, position (hkl) and phase of the 
diffracted beam is necessary. The amplitude of structure factors and positions are easily 
obtained from individual reflections. Intensities of diffraction spots and Fhkl are related as 
follows; 
I2  =  Fhkl 
 
But information regarding the phase of the diffracted beam (φhkl) is lost. There are multiple 
ways to obtain the ‘phase information’. A Patterson function like the one shown in Figure 
4 is used to obtain the phase information.  
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Figure 4. Patterson auto-correlation function (Putnam et al, 2007) 
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Mutiple/Single Isomorphous replacement (MIR/SIR): 
 Diffraction data is collected for native and heavy atom derivates of crystals & the 
positions of the heavy atoms are identified based on the difference in intensity between the 
data sets from an isomorphous Patterson map. Hence, structure may be solved. 
 
Multiple/Single wavelength Anomolous Diffraction (MAD/SAD):   
 The difference in anomalous scattering intensity inherent to elements with higher orbitals 
naturally present in protein molecules (Eg: Sulfur) or artificially incorporated into protein 
molecules (Eg: Selenium) is used to determine the positions of these anomalous scatters 
from anomalous difference Patterson maps. The information is then used to determine the 
structure of the protein under investigation.  
 
Molecular replacement (MR): 
 Initial phase information is calculated from a model protein with appreciable sequence 
similarity to the protein currently under investigation. The model protein is repositioned 
onto the current diffraction data with as good an agreement as possible. Calculated phases 
are combined with the experimental data carefully so that minimal bias from the model 
protein is imposed onto the structure of the new protein. 
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A.03 Refinement: 
 Refinement is a process of improving the electron density map after the initial solution for 
the electron density function is obtained by adjusting the positions of atoms to minimize 
the discrepancies between the observed and calculated amplitudes using stereochemistry 
and electric and chemical bond restraints. There are several cycles of refinement that are 
run to ultimately generate acceptable atomic models based on the original diffraction data.  
 
 
A.04 X-ray crystallography glossary – important terms (Rhodes, 2000):  
For data collection statistics:  
Rmerge: 
It is the measure of agreement between multiple non-symmetry related measurements of 
the same reflections and is given by;  
Rmerge = Σh Σi | Ii - <I>| / Σh Σi Ii - 
 
Ii is the ith intensity measurement of reflection h, and <I> is the average intensity from 
multiple observations. Acceptable values for Rmerge are frequently below 10%.  
 
Redundancy: 
 Redundancy is given by; 
(Number of measured reflections) / (Number of unique reflections) 
Higher redundancy values (>3) are usually acceptable.  
  133 
 
I/σ(I): 
 Higher signal to noise ratio depicted by I/σ(I) (> 2 in the highest resolution shell) is highly 
recommended.  
 
For refinement: 
Rfactor:  
It is a measurement of the agreement of the crystallographic model obtained from the 
calculated intensities and those from the original diffraction data for individual reflections. 
Rfactor is given by; 
Rfactor  = Σ ||Fobs| - |Fcalc|| / Σ |Fobs|  
Final Rfactor  in the range of 0-0.3 are acceptable and a low Rfactor   value is indicative of 
good model quality.  
 
Rfree: 
Rfree is calculated similar to the way that Rfactor is calculated using a small set of randomly 
selected reflections (test set) that is not used during the refinement process. Frequently Rfree  
is only slightly greater than Rfactor and an acceptable difference between the two values is 
not more than 6%. This strategy of using Rfree values in addition to Rfactor helps in 
minimizing bias in the refinement process that may result in incorrect calculation of 
models in subsequent refinement runs.  
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TLS Motion Determination (TLSMD) (Merrit, 2006): 
This is an additional strategy in the refinement process that may be used during refinement 
runs. A crystal structure is analyzed for evidence of flexibility within the domain or 
between domains etc. Individual chains of the structure are partitioned into segments 
modeled as rigid bodies.  The segments are evaluated for TLS 
(Translation/Libration/Screw) vibrational motion. Multiple trials of partitioning the chains 
is scored against the atomic displacement parameters ("B-factor values").  
 
B. Small Angle X-ray scattering (SAXS) (Putnam et al, 2007): 
 Although, X-ray crystallography provides unparalleled information at atomic resolution 
about proteins there are several pitfalls to the technique including intense sample 
preparation, requirement for crystals and possibility that the solution state of the protein is 
different from that in a crystal even though protein crystals have appreciable solvent 
content. SAXS becomes a very useful technique in such cases where obtaining diffractable 
crystals is a serious problem. SAXS can provide low-resolution models of proteins and 
frequently aid in designing protein constructs that may be amenable to crystallization. 
Further the modest sample preparation and data collection specifications makes SAXS a 
highly attractive technique in general and specifically when solution state studies of 
proteins need to be performed. It is also worth noting that SAXS is an extremely useful 
technique to monitor gross conformational changes, large unstructured regions and 
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determine the overall size of the protein more accurately than the frequently employed gel 
filtration studies.   
 
B.01 SAXS basics:  
Unlike crystallography where a complex Patterson function that assimilates directional 
inter-atomic distances (See Figure 4 in previous section) is used, the pair-distribution 
function utilized in SAXS studies resolves equivalent distances within a scattering unit 
without any information retained of the directionality (Figure 5). SAXS measurements 
generate scattering profiles that are plotted with scattering intensity (I(q)) as the Y-axis and 
momentum transfer (q = 4πsinθ/λ, where 2θ is the scattering angle ) as X-axis. SAXS is a  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Pair distribution function (Putnam et al, 2007) 
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difference technique and hence the protein sample has to be in the exact buffer, which is 
used to obtain a scattering profile for buffer alone. This is achieved by either dialyzing the 
protein extensively against the same buffer or performing gel-filtration runs prior to data 
collection.  
 
B.02 SAXS glossary –important terms:  
Radius of gyration (Rg): 
 Rg, distribution of the mass of a macromolecule around its centre of gravity, is the square 
root of the averaged squared distance of each scatterer from the centre of the 
macromolecule. It may be described in the equation;  
ln I(q) = ln I(0) – Rg2 /3 * q2 
Guinier analysis plot of ln I(q) vs q2 is a straight line at low q and is used to estimate Rg. A 
non-linear dependence of ln I(q) vs q2 is indicative of  presence of aggregation. SAXS data 
is collected at multiple different concentrations above 1mg/mL to determine if there is any 
aggregation in the sample that can have deleterious effects to further analysis of the data.  
 
I(0): 
 I(0) or intensity measured at q=0 is determined by extrapolation of Guinier analysis plot. 
It is an important parameter to determine the molecular weight of the protein sample & 
functions as another parameter to check the quality of the collected data.  
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Kratky plot: 
 The Kratky plot is an important tool to estimate the folding of protein samples. It is a plot 
of q2I(q) as a function of q. For folded domains the plot appears like a bell shaped parabola 
while elongated and unstructured macromolecules appear to plateau as a function of the 
extent of unfoldedness (Figure 6).  
 
 
 
 
 
 
 
 
 
 
Pair-distribution function P(r): 
P(r) function describes a distribution of all equivalent paired sets of distances within 
macromolecules. P(r) function is described by; 
I(q) = int p(r) * {sin (q.r)/q.r} dr   
Figure 6. Standard Kratky plot for proteins of different shapes (Putnam 
et al, 2007) 
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where r is a measure of distance. Slight variations in the function are indicative of 
conformational changes in the macromolecule. Globular molecules have a P(r) with a 
single peak while multidomain proteins have multiple peaks and more elongated proteins 
can have multiple peaks with long tail at larger r values (Figure 7).  
 
 
 
 
 
 
 
 
 
 
 
B.03 Solution structure modeling: 
 Ab-initio shape reconstruction is frequently carried out using SAXS data. Using the P(r) 
distribution function and information generated from the scattering profile low-resolution 
SAXS envelopes of proteins are generated. Multiple different programs may be used to do 
so including DAMMIN or GASBOR and results from either compared with each other. 
Further, multiple runs of the same program is performed which is essentially simulated 
annealing using a bead-model in DAMMIN and chain-like ensemble of dummy residues in 
Figure 7. P(r) function of proteins of different shapes (Putnam et al, 2007) 
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GASBOR that best fits the scattering data. The SAXS envelopes generated from these 
multiple runs are averaged using SUPCOMB suite of programs to generate unbiased non-
over fitted models of proteins in solution. If atomic structure of the protein under 
investigation is known then theoretical SAXS profile from the atomic structure of the 
protein may be compared with the experimental SAXS profile of the protein to investigate 
any differences between the crystal & solution structures. If atomic structure of only 
individual domains of full-length protein is known then each may be fitted into the SAXS 
envelope. Further, using programs like BUNCH, CRYSOL, CORAL and CREDO missing 
loops or domains may be built into or adjoining the atomic structure using SAXS 
scattering profile as a guide. 
 
C. Analytical Ultracentrifugation (AUC) (Ralston, 1993):  
 Analytical ultracentrifugation is yet another biophysical technique to access the shape and 
size of a macromolecules. Variants of the technique can be used to investigate 
conformational changes in proteins, oligomerization state of proteins as well as visualize 
complexation with various ligands.  
 The basic principles involved in analytical ultracentrifugation experiment are described 
hereunder. A solute suspended in a solvent that begins to move along a radial path when 
centrifugal force is applied (as is experienced by the solute if it is centrifuged at high 
speed) experiences three forces during its sedimentation process, namely gravitational 
force, buoyant force and frictional force. For a time scale of 10-6 seconds the three forces 
balance each other out since frictional force is a retarding force. A term, sedimentation 
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coefficient (s) has thus been defined based on the above considerations that depend on the 
physical properties of the particle. It has units of seconds & is given by,  
s = υ/ω2r 
or velocity (υ) of the particle per unit gravitational acceleration (ω2r). It depends on the 
molar weight of the sedimenting particle and is inversely proportional to fractional 
coefficient.  
 A schematic representation of a sedimenting boundary (of sedimenting particles) is shown 
in Figure 8.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Double sector centerpiece and a representative sedimentation 
profile (Ralston, 1993) 
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In a general experiment, the sample is sedimented at high speed and at every couple of 
seconds the reference and the sample sectors are imaged.  A schematic diagram of the 
Beckman Optima XL-A analytical ultracentrifuge is shown is Figure 9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Optical system of Beckman Optima XL-A Analytical 
ultracentrifuge.  (Ralston, 1993) 
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 The optical system of an AUC instrument measures differences in absorbance or light 
scattering between the reference sector and the sample sector. There are two optical 
systems, one that measures interference (based on the light scattered by the samples) from 
the sample and one that measures absorbance from absorbing molecules from the sample 
(say protein molecules that absorb at 280nm). There are two major experiments that are 
performed – sedimentation velocity experiments and sedimentation equilibrium 
experiments.  
 In sedimentation velocity experiments, a homogenous solution is subjected to a high 
angular velocity in the instrument that leads to depletion of sample molecules from the 
meniscus and formation of a sharp boundary that separates the depleting sample molecules 
from the homogenous concentration of the sedimenting solute. Integrating and processing 
the data to generate a size-distribution (c(s)) vs sedimentation coefficient curve & hence 
obtain the sedimentation coefficient of the solute particle.  
 In a sedimentation equilibrium experiment, a small volume of a homogenous sample 
solution is subjected to lower angular velocity in the instrument. As the sedimentation 
process proceeds with increased concentration of solute at the bottom of the cell, diffusion 
acts as an opposing force. The concentration of the solute increases exponentially towards 
the bottom of the cell once equilibrium is reached between the two forces. This procedure 
enables one to determine the molecular weight of the sedimenting particle by measuring 
concentrations at different points in the equilibrium curve.  
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D. Fluorescence Anisotropy (Invitrogen, 2006): 
 Fluorescence anisotropy is used to determine the dissociation constants of a binding event 
say, 
                                                      P + L                
 where, P is the protein, L is the ligand  & PL is the protein-ligand complex. Plane 
polarized light is used to excite fluorescent ligands. Small fluorescent ligands tend to 
tumble too quickly and depolarize during their fluorescence lifetimes (time between 
excitation and emission). When bound to a macromolecular protein the fluorescent ligand 
rotates less rapidly and tends to emit polarized light. The intensity of the emitted light is 
measured in both parallel and perpendicular planes (Figure 10). Fluorescence anisotropy is 
given by  
Anisotropy = [III  - Iper /  III  - 2Iper]  
where, III is the intensity measured in the parallel (vertical) direction to the excitation plane 
polarized light and Iper is the intensity measured in the perpendicular (horizontal) direction 
to the excitation plane polarized light.  
 
 
 
 
 
 
PL 
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Figure 10. a. Schematic representation of small and large complexes and their 
differences in anisotropy. b. Schematic representation of general detection 
protocol of a fluorescence polarization experiment (Invitrogen, 2006) 
a. 
b. 
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 Binding isotherms are generated by titrating increasing concentration of the 
macromolecule against a constant concentration of the ligand till no change in anisotropy 
is observed or in other words saturation is achieved. Further, using a one site binding 
equation for a ligand-macromolecule interaction that obeys this relationship a dissociation 
constant (Kd) is calculated. One site binding equation is given as, 
Y = Bmax*X/(Kd + X) 
 where, Bmax is the maximal specific binding in units of anisotropy or percent ligand 
bound, X is the concentration of the ligand and Y is increasing units of anisotropy or 
percent ligand bound.  
  
E. Tobacco Etch Virus- protease (TEV) purification: 
 TEV-protease plasmid with an N-terminal His-tag and S219V mutation that prevents the 
autolysis of the protein improving its yield by almost 100-fold was a kind gift from Dr. 
Takeharu Kawano (Kapust et al, 2001). The plasmid is Ampicillin resistant & an overnight 
culture was grown overnight with ~100µg/L final concentration of Ampicillin. Next day, 
10-20ml of the overnight culture was added per litre of culture. The protein was grown at 
37°C till OD ~0.6 was reached. The culture was induced with 1mM IPTG & the 
temperature was reduced to 30°C and the cells were harvested after about 4-6hrs of 
shaking, pelleted and frozen at -80°C. The cells were thawed and run on a Ni-NTA column 
equilibrated in 50mM sodium phosphate dibasic pH 8.0, 200mM NaCl, 10% glycerol, 
5mM imidazole and eluted with 250mM imidazole. The eluted protein was concentrated 
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and further purified on a gel filtration column pre-equilibrated in 25mM sodium phosphate 
pH 7.5, 100mM NaCl, 10% glycerol. The fractions with TEV-protease (molecular weight 
~25kDa) were pooled, concentrated to 1.5mg/mL and flash frozen and stored at -80°C. 
About 45-50mg of total protein was obtained per litre.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  147 
References:  
  
Anderson, W. F., et al. (1981). "Structure of the cro repressor from bacteriophage lambda 
and its interaction with DNA." Nature 290(5809): 754-758. 
 Adams,	  P.	  D.,	  et	  al.	  (2010).	  "PHENIX:	  a	  comprehensive	  Python-­‐based	  system	  for	  macromolecular	  structure	  solution."	  Acta	  Crystallogr	  D	  Biol	  Crystallogr	  66(Pt	  2):	  213-­‐221.	  
 Allaire,	  M.	  and	  L.	  Yang	  (2011).	  "Biomolecular	  solution	  X-­‐ray	  scattering	  at	  the	  National	  Synchrotron	  Light	  Source."	  J	  Synchrotron	  Radiat	  18(1):	  41-­‐44.	  	  Aprile,	  F.	  A.,	  et	  al.	  (2013).	  "Hsp70	  oligomerization	  is	  mediated	  by	  an	  interaction	  between	  the	  interdomain	  linker	  and	  the	  substrate-­‐binding	  domain."	  PLoS	  One	  8(6):	  e67961.	  
 
ATSAS. Version 5.3 © ATSAS team 1999-2008. 
 Biswas,	  P.	  S.,	  et	  al.	  (2010).	  "Phosphorylation	  of	  IRF4	  by	  ROCK2	  regulates	  IL-­‐17	  and	  IL-­‐21	  production	  and	  the	  development	  of	  autoimmunity	  in	  mice."	  J	  Clin	  Invest	  120(9):	  3280-­‐3295.	  	   	  Brass,	  A.	  L.,	  et	  al.	  (1996).	  "Pip,	  a	  lymphoid-­‐restricted	  IRF,	  contains	  a	  regulatory	  domain	  that	  is	  important	  for	  autoinhibition	  and	  ternary	  complex	  formation	  with	  the	  Ets	  factor	  PU.1."	  Genes	  Dev	  10(18):	  2335-­‐2347.	  
 Brass,	  A.	  L.,	  et	  al.	  (1999).	  "Assembly	  requirements	  of	  PU.1-­‐Pip	  (IRF-­‐4)	  activator	  complexes:	  inhibiting	  function	  in	  vivo	  using	  fused	  dimers."	  EMBO	  J	  18(4):	  977-­‐991.	  
 Briggs,	  S.	  D.	  and	  T.	  E.	  Smithgall	  (1999).	  "SH2-­‐kinase	  linker	  mutations	  release	  Hck	  tyrosine	  kinase	  and	  transforming	  activities	  in	  Rat-­‐2	  fibroblasts."	  J	  Biol	  Chem	  274(37):	  26579-­‐26583.	  
 Brookes,	  E.,	  et	  al.	  (2010).	  "Developments	  in	  the	  US-­‐SOMO	  bead	  modeling	  suite:	  new	  features	  in	  the	  direct	  residue-­‐to-­‐bead	  method,	  improved	  grid	  routines,	  and	  influence	  of	  accessible	  surface	  area	  screening."	  Macromol	  Biosci	  10(7):	  746-­‐753.	  	   	  Brookes,	  E.,	  et	  al.	  (2010).	  "The	  implementation	  of	  SOMO	  (SOlution	  MOdeller)	  in	  the	  UltraScan	  analytical	  ultracentrifugation	  data	  analysis	  suite:	  enhanced	  capabilities	  allow	  the	  reliable	  hydrodynamic	  modeling	  of	  virtually	  any	  kind	  of	  biomacromolecule."	  Eur	  Biophys	  J	  39(3):	  423-­‐435.	  	  
  148 
  
Biswas, P. S., et al. (2010). "IRF4 and its regulators: evolving insights into the 
pathogenesis of inflammatory arthritis?" Immunol Rev 233(1): 79-96. 
  
Biswas, P. S., et al. (2010). "Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-
21 production and the development of autoimmunity in mice." J Clin Invest 120(9): 3280-
3295. 
  
Brown, M. S. and J. L. Goldstein (1997). "The SREBP pathway: regulation of cholesterol 
metabolism by proteolysis of a membrane-bound transcription factor." Cell 89(3): 331-
340. 
  
Carrie N. Arnold, E. P., Nora G. Smart, Beutler B. (2013, Dec 12, 2013). "Record for 
honey." Retrieved Accessed Jun 29, 2014, from http://mutagenetix.utsouthwestern.edu:80. 
 Chen,	  W.,	  et	  al.	  (2008).	  "Insights	  into	  interferon	  regulatory	  factor	  activation	  from	  the	  crystal	  structure	  of	  dimeric	  IRF5."	  Nat	  Struct	  Mol	  Biol	  15(11):	  1213-­‐1220.	  	  Chandra,	  V.,	  et	  al.	  (2008).	  "Structure	  of	  the	  intact	  PPAR-­‐gamma-­‐RXR-­‐	  nuclear	  receptor	  complex	  on	  DNA."	  Nature	  456(7220):	  350-­‐356.	  	  
Clancy, S. (2008). "RNA transcription by RNA polymerase: prokaryotes vs eukaryote." 
Nature Education 1(1). 
  
David S. Pederson, N. H. H. (1994). Transcription factors and DNA replication. 
Transcription factors and DNA replication. USA, R. G. Landes company: 1-7. 
  
De Cesare, D. and P. Sassone-Corsi (2000). "Transcriptional regulation by cyclic AMP-
responsive factors." Prog Nucleic Acid Res Mol Biol 64: 343-369. 
  
De Silva, N. S., et al. (2012). "The diverse roles of IRF4 in late germinal center B-cell 
differentiation." Immunol Rev 247(1): 73-92. 
  
Douet, V., et al. (2007). "DNA methylation and Sp1 binding determine the tissue-specific 
transcriptional activity of the mouse Abcc6 promoter." Biochem Biophys Res Commun 
354(1): 66-71. 
  
Eguchi, J., et al. (2013). "Interferon regulatory factor 4 regulates obesity-induced 
inflammation through regulation of adipose tissue macrophage polarization." Diabetes 
62(10): 3394-3403. 
  
Eguchi, J., et al. (2011). "Transcriptional control of adipose lipid handling by IRF4." Cell 
Metab 13(3): 249-259. 
  149 
  
Eisenbeis, C. F., et al. (1993). "PU.1 is a component of a multiprotein complex which 
binds an essential site in the murine immunoglobulin lambda 2-4 enhancer." Mol Cell Biol 
13(10): 6452-6461. 
  
Eisenbeis, C. F., et al. (1995). "Pip, a novel IRF family member, is a lymphoid-specific, 
PU.1-dependent transcriptional activator." Genes Dev 9(11): 1377-1387. 
  
Escalante, C. R., et al. (2002). "Crystal structure of PU.1/IRF-4/DNA ternary complex." 
Mol Cell 10(5): 1097-1105. 
  
Fabrizi, M., et al. (2014). "IL-21 is a major negative regulator of IRF4-dependent lipolysis 
affecting Tregs in adipose tissue and systemic insulin sensitivity." Diabetes 63(6): 2086-
2096. 
 George,	  R.	  A.	  and	  J.	  Heringa	  (2002).	  "An	  analysis	  of	  protein	  domain	  linkers:	  their	  classification	  and	  role	  in	  protein	  folding."	  Protein	  Eng	  15(11):	  871-­‐879.	  
  
Gonzaga-Jauregui, C., et al. (2012). "Human genome sequencing in health and disease." 
Annu Rev Med 63: 35-61. 
  
Gupta, S., et al. (2001). "Stage-specific modulation of IFN-regulatory factor 4 function by 
Kruppel-type zinc finger proteins." J Immunol 166(10): 6104-6111. 
  
Gupta, S., et al. (1999). "Lineage-specific modulation of interleukin 4 signaling by 
interferon regulatory factor 4." J Exp Med 190(12): 1837-1848. 
  
Harvey Lodish, A. B., S Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James 
Darnell (2000). Eukaryotic Transcription Activators and Repressors. Molecular Cell 
Biology. USA, W. H. Freeman. 
  
He, J. and P. Furmanski (1995). "Sequence specificity and transcriptional activation in the 
binding of lactoferrin to DNA." Nature 373(6516): 721-724. 
  
He, X., et al. (2012). "Evolutionary origins of transcription factor binding site clusters." 
Mol Biol Evol 29(3): 1059-1070. 
  
Heineke, J. and J. D. Molkentin (2006). "Regulation of cardiac hypertrophy by intracellular 
signalling pathways." Nat Rev Mol Cell Biol 7(8): 589-600. 
  
Hoffmann, A., et al. (2006). "Transcriptional regulation via the NF-kappaB signaling 
module." Oncogene 25(51): 6706-6716. 
  
  150 
Honda, K., et al. (2004). "Role of a transductional-transcriptional processor complex 
involving MyD88 and IRF-7 in Toll-like receptor signaling." Proc Natl Acad Sci U S A 
101(43): 15416-15421. 
  
Honda, K., et al. (2005). "IRF-7 is the master regulator of type-I interferon-dependent 
immune responses." Nature 434(7034): 772-777. 
  
Horvath, C. M. (2000). "STAT proteins and transcriptional responses to extracellular 
signals." Trends Biochem Sci 25(10): 496-502. 
 
Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massague J. 2001. The TGF beta receptor 
activation process: an inhibitor- to substrate-binding switch. Molecular cell 8(3):671-682. 
 Ikebe,	  M.,	  et	  al.	  (1998).	  "A	  hinge	  at	  the	  central	  helix	  of	  the	  regulatory	  light	  chain	  of	  myosin	  is	  critical	  for	  phosphorylation-­‐dependent	  regulation	  of	  smooth	  muscle	  myosin	  motor	  activity."	  J	  Biol	  Chem	  273(28):	  17702-­‐17707.	  
 
Invitrogen. 2006. Technical Resource guide- Fluorescence polarization. Fourth ed. 
  
Ihle, J. N. (2001). "The Stat family in cytokine signaling." Curr Opin Cell Biol 13(2): 211-
217. 
  
Jiang, D. S., et al. (2013). "Role of interferon regulatory factor 4 in the regulation of 
pathological cardiac hypertrophy." Hypertension 61(6): 1193-1202. 
  
Kaptein, R., et al. (1985). "A protein structure from nuclear magnetic resonance data. lac 
repressor headpiece." J Mol Biol 182(1): 179-182. 
  
Karin, M. and Y. Ben-Neriah (2000). "Phosphorylation meets ubiquitination: the control of 
NF-[kappa]B activity." Annu Rev Immunol 18: 621-663. 
 
Kapust RB, Tozser J, Fox JD, Anderson DE, Cherry S, Copeland TD, Waugh DS. 2001. 
Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants 
with wild-type catalytic proficiency. Protein engineering 14(12):993-1000. 
  
Kawai, T., et al. (2004). "Interferon-alpha induction through Toll-like receptors involves a 
direct interaction of IRF7 with MyD88 and TRAF6." Nat Immunol 5(10): 1061-1068. 
  
Kim, J., et al. (2003). "Methylation-sensitive binding of transcription factor YY1 to an 
insulator sequence within the paternally expressed imprinted gene, Peg3." Hum Mol Genet 
12(3): 233-245. 
  
  151 
Kingston, R. E. and M. R. Green (1994). "Modeling eukaryotic transcriptional activation." 
Curr Biol 4(4): 325-332. 
  
Klein, U., et al. (2006). "Transcription factor IRF4 controls plasma cell differentiation and 
class-switch recombination." Nat Immunol 7(7): 773-782. 
 Kleywegt,	  G.	  J.	  and	  T.	  A.	  Jones	  (1994).	  "Detection,	  delineation,	  measurement	  and	  display	  of	  cavities	  in	  macromolecular	  structures."	  Acta	  Crystallogr	  D	  Biol	  Crystallogr	  
50(Pt	  2):	  178-­‐185.	  
 LaFevre-­‐Bernt,	  M.,	  et	  al.	  (1998).	  "Intramolecular	  regulatory	  interactions	  in	  the	  Src	  family	  kinase	  Hck	  probed	  by	  mutagenesis	  of	  a	  conserved	  tryptophan	  residue."	  J	  Biol	  Chem	  273(48):	  32129-­‐32134.	  
  
Larson, J. S., et al. (1988). "Activation in vitro of sequence-specific DNA binding by a 
human regulatory factor." Nature 335(6188): 372-375. 
  
Latchman, D. S. (2008). DNA sequences, transcription factors and chromatin structure. 
Eukaryotic transcription factors. USA, Elsevier Ltd.: 1-24. 
  
Lee, T. H. and N. Maheshri (2012). "A regulatory role for repeated decoy transcription 
factor binding sites in target gene expression." Mol Syst Biol 8: 576. 
 Levi,	  B.	  Z.,	  et	  al.	  (2002).	  "ICSBP/IRF-­‐8	  transactivation:	  a	  tale	  of	  protein-­‐protein	  interaction."	  J	  Interferon	  Cytokine	  Res	  22(1):	  153-­‐160.	  
 
Li, P., et al. (2012). "BATF-JUN is critical for IRF4-mediated transcription in T cells." 
Nature 490(7421): 543-546. 
  
Lin, R., et al. (1998). "Virus-dependent phosphorylation of the IRF-3 transcription factor 
regulates nuclear translocation, transactivation potential, and proteasome-mediated 
degradation." Mol Cell Biol 18(5): 2986-2996. 
  
Lin, R., et al. (1999). "Structural and functional analysis of interferon regulatory factor 3: 
localization of the transactivation and autoinhibitory domains." Mol Cell Biol 19(4): 2465-
2474. 
  
Ling, G., et al. (2007). "Transcriptional regulation of human CYP2A13 expression in the 
respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation." Mol 
Pharmacol 71(3): 807-816. 
 Mamane,	  Y.,	  et	  al.	  (2000).	  "Posttranslational	  regulation	  of	  IRF-­‐4	  activity	  by	  the	  immunophilin	  FKBP52."	  Immunity	  12(2):	  129-­‐140.	  
  152 
	   	  
Marie, I., et al. (2000). "Phosphorylation-induced dimerization of interferon regulatory 
factor 7 unmasks DNA binding and a bipartite transactivation domain." Mol Cell Biol 
20(23): 8803-8814. 
  
Mayr, B. and M. Montminy (2001). "Transcriptional regulation by the phosphorylation-
dependent factor CREB." Nat Rev Mol Cell Biol 2(8): 599-609. 
  McCoy,	  A.	  J.,	  et	  al.	  (2007).	  "Phaser	  crystallographic	  software."	  J	  Appl	  Crystallogr	  40(Pt	  4):	  658-­‐674.	  
 
McKay, D. B. and T. A. Steitz (1981). "Structure of catabolite gene activator protein at 2.9 
A resolution suggests binding to left-handed B-DNA." Nature 290(5809): 744-749. 
  
Medzhitov, R., et al. (1998). "MyD88 is an adaptor protein in the hToll/IL-1 receptor 
family signaling pathways." Mol Cell 2(2): 253-258. 
 Meraro,	  D.,	  et	  al.	  (1999).	  "Protein-­‐protein	  and	  DNA-­‐protein	  interactions	  affect	  the	  activity	  of	  lymphoid-­‐specific	  IFN	  regulatory	  factors."	  J	  Immunol	  163(12):	  6468-­‐6478.	  	   	  Merrit,	  J.	  P.	  E.	  A.	  (2006).	  "TLSMD	  web	  server	  for	  the	  generation	  of	  multi-­‐group	  TLS	  models."	  J.	  Appl.	  Cryst.	  39:	  109-­‐111.	  
 Mishra,	  R.,	  et	  al.	  (2002).	  "PAX6,	  paired	  domain	  influences	  sequence	  recognition	  by	  the	  homeodomain."	  J	  Biol	  Chem	  277(51):	  49488-­‐49494.	  
 
Molkentin, J. D. and G. W. Dorn, 2nd (2001). "Cytoplasmic signaling pathways that 
regulate cardiac hypertrophy." Annu Rev Physiol 63: 391-426. 
  
Mudter, J., et al. (2008). "The transcription factor IFN regulatory factor-4 controls 
experimental colitis in mice via T cell-derived IL-6." J Clin Invest 118(7): 2415-2426. 
 
Naar, A. M., et al. (2001). "Transcriptional coactivator complexes." Annu Rev Biochem 
70: 475-501. 
 Nagulapalli,	  S.	  and	  M.	  L.	  Atchison	  (1998).	  "Transcription	  factor	  Pip	  can	  enhance	  DNA	  binding	  by	  E47,	  leading	  to	  transcriptional	  synergy	  involving	  multiple	  protein	  domains."	  Mol	  Cell	  Biol	  18(8):	  4639-­‐4650.	  
 
Negishi, H., et al. (2005). "Negative regulation of Toll-like-receptor signaling by IRF-4." 
Proc Natl Acad Sci U S A 102(44): 15989-15994. 
 
  153 
Ning, S. (2013). "IRF4 as an Oncogenic Biomarker for Hematological Malignancies." J 
Oncobiomarkers 1(1): 6-11.	  
  
Ohlendorf, D. H., et al. (1982). "The molecular basis of DNA-protein recognition inferred 
from the structure of cro repressor." Nature 298(5876): 718-723. 
  
Pabo, C. O. and M. Lewis (1982). "The operator-binding domain of lambda repressor: 
structure and DNA recognition." Nature 298(5873): 443-447. 
  
Pabo, C. O. and R. T. Sauer (1992). "Transcription factors: structural families and 
principles of DNA recognition." Annu Rev Biochem 61: 1053-1095. 
 Pelikan,	  M.,	  et	  al.	  (2009).	  "Structure	  and	  flexibility	  within	  proteins	  as	  identified	  through	  small	  angle	  X-­‐ray	  scattering."	  Gen	  Physiol	  Biophys	  28(2):	  174-­‐189.	  
 Petoukhov,	  M.	  V.,	  Franke,	  D.,	  Shkumatov,	  A.V.,	  Tria,	  G.,	  Kikhney,	  A.G.,	  Gajda,	  M.,	  Gorba,	  C.,	  Mertens,	  H.D.T.,	  Konarev,	  P.V.	  and	  Svergun,	  D.I.	  (2012).	  "New	  developments	  in	  the	  ATSAS	  program	  package	  for	  small-­‐angle	  scattering	  data	  analysis."	  J.	  Appl.	  Cryst.	  45:	  	  342-­‐350	  
 
picture W. http://www.cmmp.ucl.ac.uk/~ijf/3c25/bravais.gif 
 
Perkel, J. M. and M. L. Atchison (1998). "A two-step mechanism for recruitment of Pip by 
PU.1." J Immunol 160(1): 241-252. 
  
Pongubala, J. M., et al. (1993). "Effect of PU.1 phosphorylation on interaction with NF-
EM5 and transcriptional activation." Science 259(5101): 1622-1625. 
  
Pratt, W. B. (1997). "The role of the hsp90-based chaperone system in signal transduction 
by nuclear receptors and receptors signaling via MAP kinase." Annu Rev Pharmacol 
Toxicol 37: 297-326. 
  
Pugh, B. F. (2001). Basic Machinery of Transcription. Transcription factors. J. Locker. 
USA, Canada, BIOS Scientific Publishers Limited: 1-16. 
 
Putnam CD, Hammel M, Hura GL, Tainer JA. 2007. X-ray solution scattering (SAXS) 
combined with crystallography and computation: defining accurate macromolecular 
structures, conformations and assemblies in solution. Quarterly reviews of biophysics 
40(3):191-285. 
 
Pymol. The PyMol Molecular Graphics System, Version #, Schrodinger, LLC 
 
  154 
Qin,	  B.	  Y.,	  et	  al.	  (2003).	  "Crystal	  structure	  of	  IRF-­‐3	  reveals	  mechanism	  of	  autoinhibition	  and	  virus-­‐induced	  phosphoactivation."	  Nat	  Struct	  Biol	  10(11):	  913-­‐921.	  	   	  Qin,	  B.	  Y.,	  et	  al.	  (2005).	  "Crystal	  structure	  of	  IRF-­‐3	  in	  complex	  with	  CBP."	  Structure	  
13(9):	  1269-­‐1277.	  	  Rai,	  N.,	  et	  al.	  (2005).	  "SOMO	  (SOlution	  MOdeler)	  differences	  between	  X-­‐Ray-­‐	  and	  NMR-­‐derived	  bead	  models	  suggest	  a	  role	  for	  side	  chain	  flexibility	  in	  protein	  hydrodynamics."	  Structure	  13(5):	  723-­‐734.	  	  
Ralston G. 1993. Introduction to Analytical Ultracentrifugation. 
 Reddy	  Chichili,	  V.	  P.,	  et	  al.	  (2013).	  "Linkers	  in	  the	  structural	  biology	  of	  protein-­‐protein	  interactions."	  Protein	  Sci	  22(2):	  153-­‐167.	  
 Rengarajan,	  J.,	  et	  al.	  (2002).	  "Interferon	  regulatory	  factor	  4	  (IRF4)	  interacts	  with	  NFATc2	  to	  modulate	  interleukin	  4	  gene	  expression."	  J	  Exp	  Med	  195(8):	  1003-­‐1012.	  
 
Rhodes G. 2000. Judging the Quality of Macromolecular Models. p A Glossary of Terms 
from Crystallography, NMR, and Homology Modeling. 
 Robinson,	  C.	  R.	  and	  R.	  T.	  Sauer	  (1998).	  "Optimizing	  the	  stability	  of	  single-­‐chain	  proteins	  by	  linker	  length	  and	  composition	  mutagenesis."	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  
95(11):	  5929-­‐5934.	  
 
Read more : http://www.ehow.com/how_8725889_cite-pymol.html. 
 
Rockman, H. A., et al. (2002). "Seven-transmembrane-spanning receptors and heart 
function." Nature 415(6868): 206-212. 
 Rubio-­‐Cosials,	  A.,	  et	  al.	  (2011).	  "Human	  mitochondrial	  transcription	  factor	  A	  induces	  a	  U-­‐turn	  structure	  in	  the	  light	  strand	  promoter."	  Nat	  Struct	  Mol	  Biol	  18(11):	  1281-­‐1289.	  
 Sali,	  A.	  and	  T.	  L.	  Blundell	  (1993).	  "Comparative	  protein	  modelling	  by	  satisfaction	  of	  spatial	  restraints."	  J	  Mol	  Biol	  234(3):	  779-­‐815.	  
  
Sankar, S., et al. (2006). "IKK-i signals through IRF3 and NFkappaB to mediate the 
production of inflammatory cytokines." Cell Signal 18(7): 982-993. 
  
Schevitz, R. W., et al. (1985). "The three-dimensional structure of trp repressor." Nature 
317(6040): 782-786. 
  155 
 Schneidman-­‐Duhovny,	  D.,	  et	  al.	  (2010).	  "FoXS:	  a	  web	  server	  for	  rapid	  computation	  and	  fitting	  of	  SAXS	  profiles."	  Nucleic	  Acids	  Res	  38(Web	  Server	  issue):	  W540-­‐544.	  	   	  Schneidman-­‐Duhovny,	  D.,	  et	  al.	  (2013).	  "Accurate	  SAXS	  profile	  computation	  and	  its	  assessment	  by	  contrast	  variation	  experiments."	  Biophys	  J	  105(4):	  962-­‐974.	  	    	  
Servant, M. J., et al. (2001). "Identification of distinct signaling pathways leading to the 
phosphorylation of interferon regulatory factor 3." J Biol Chem 276(1): 355-363. 
  
Shaffer, A. L., et al. (2008). "IRF4 addiction in multiple myeloma." Nature 454(7201): 
226-231. 
  
Sharma, S., et al. (2003). "Triggering the interferon antiviral response through an IKK-
related pathway." Science 300(5622): 1148-1151. 
 
Shuchismita Dutta RKG, and Catherine L. Lawson. Looking at Structures: Introduction to 
Biological Assemblies and the PDB Archive. 
 
Smith, R. P., et al. (2013). "Massively parallel decoding of mammalian regulatory 
sequences supports a flexible organizational model." Nat Genet 45(9): 1021-1028. 
 
Suzuki, S., et al. (2004). "Critical roles of interferon regulatory factor 4 in 
CD11bhighCD8alpha- dendritic cell development." Proc Natl Acad Sci U S A 101(24): 
8981-8986. 
 Svergun,	  D.	  I.	  (1992).	  "Determination	  of	  the	  regularization	  parameter	  in	  indirect-­‐transform	  methods	  using	  perceptual	  criteria."	  J.	  Appl.	  Crystllogr.	  25:	  495-­‐503.	  	   	  Svergun,	  D.	  I.,	  et	  al.	  (2001).	  "Determination	  of	  domain	  structure	  of	  proteins	  from	  X-­‐ray	  solution	  scattering."	  Biophys	  J	  80(6):	  2946-­‐2953.	  	   	  Svergun,	  M.	  B.	  K.	  a.	  D.	  I.	  (2001).	  "Automated	  matching	  of	  high-­‐	  and	  low-­‐resolution	  structural	  models."	  J.	  Appl.	  Cryst.	  34:	  33-­‐41.	  
 
Takaoka, A., et al. (2005). "Integral role of IRF-5 in the gene induction programme 
activated by Toll-like receptors." Nature 434(7030): 243-249. 
  
Tamura, T., et al. (2005). "IFN regulatory factor-4 and -8 govern dendritic cell subset 
development and their functional diversity." J Immunol 174(5): 2573-2581. 
  
Thiele, D. J. (1992). "Metal-regulated transcription in eukaryotes." Nucleic Acids Res 
20(6): 1183-1191. 
  156 
 
Ugleingo P. 2013. Crystallographic Structural Data. 
 van	  Leeuwen,	  H.	  C.,	  et	  al.	  (1997).	  "Linker	  length	  and	  composition	  influence	  the	  flexibility	  of	  Oct-­‐1	  DNA	  binding."	  EMBO	  J	  16(8):	  2043-­‐2053.	  
 Weitz-­‐Schmidt,	  G.,	  et	  al.	  (2011).	  "The	  C-­‐terminal	  alphaI	  domain	  linker	  as	  a	  critical	  structural	  element	  in	  the	  conformational	  activation	  of	  alphaI	  integrins."	  J	  Biol	  Chem	  
286(49):	  42115-­‐42122.	  
 Winn,	  M.	  D.,	  et	  al.	  (2011).	  "Overview	  of	  the	  CCP4	  suite	  and	  current	  developments."	  Acta	  Crystallogr	  D	  Biol	  Crystallogr	  67(Pt	  4):	  235-­‐242.	  
 
Werner, T. (2009). The Role of Transcription Factor Binding Sites in Promoters and Their 
In Silico Detection. Bioinfomatics for systems biology. S. Krawetz. Germany, Humana 
Press. 
  
Willmann, T. and M. Beato (1986). "Steroid-free glucocorticoid receptor binds specifically 
to mouse mammary tumour virus DNA." Nature 324(6098): 688-691. 
  
Wood, M. J., et al. (2004). "Structural basis for redox regulation of Yap1 transcription 
factor localization." Nature 430(7002): 917-921. 
 Wootton,	  J.	  C.	  and	  M.	  H.	  Drummond	  (1989).	  "The	  Q-­‐linker:	  a	  class	  of	  interdomain	  sequences	  found	  in	  bacterial	  multidomain	  regulatory	  proteins."	  Protein	  Eng	  2(7):	  535-­‐543.	  
 Wriggers,	  W.,	  et	  al.	  (2005).	  "Control	  of	  protein	  functional	  dynamics	  by	  peptide	  linkers."	  Biopolymers	  80(6):	  736-­‐746.	  
 Wu,	  G.,	  et	  al.	  (2000).	  "Structural	  basis	  of	  Smad2	  recognition	  by	  the	  Smad	  anchor	  for	  receptor	  activation."	  Science	  287(5450):	  92-­‐97.	  	   	  Wu,	  J.	  W.,	  et	  al.	  (2001).	  "Crystal	  structure	  of	  a	  phosphorylated	  Smad2.	  Recognition	  of	  phosphoserine	  by	  the	  MH2	  domain	  and	  insights	  on	  Smad	  function	  in	  TGF-­‐beta	  signaling."	  Mol	  Cell	  8(6):	  1277-­‐1289.	  
  
Xu, W. D., et al. (2012). "Targeting IRF4 in autoimmune diseases." Autoimmun Rev 
11(12): 918-924. 
 Xu,	  H.	  E.,	  et	  al.	  (1999).	  "Crystal	  structure	  of	  the	  human	  Pax6	  paired	  domain-­‐DNA	  complex	  reveals	  specific	  roles	  for	  the	  linker	  region	  and	  carboxy-­‐terminal	  subdomain	  in	  DNA	  binding."	  Genes	  Dev	  13(10):	  1263-­‐1275.	  
  157 
 
Yamamoto, Y. and R. B. Gaynor (2004). "IkappaB kinases: key regulators of the NF-
kappaB pathway." Trends Biochem Sci 29(2): 72-79. 
  
Yao, S., et al. (2013). "Interferon regulatory factor 4 sustains CD8(+) T cell expansion and 
effector differentiation." Immunity 39(5): 833-845. 
  
Yee, A. A., et al. (1998). "Cooperative interaction between the DNA-binding domains of 
PU.1 and IRF4." J Mol Biol 279(5): 1075-1083. 
  
Yoneyama, M., et al. (1998). "Direct triggering of the type I interferon system by virus 
infection: activation of a transcription factor complex containing IRF-3 and CBP/p300." 
EMBO J 17(4): 1087-1095. 
 Zarate-­‐Perez,	  F.,	  et	  al.	  (2012).	  "The	  interdomain	  linker	  of	  AAV-­‐2	  Rep68	  is	  an	  integral	  part	  of	  its	  oligomerization	  domain:	  role	  of	  a	  conserved	  SF3	  helicase	  residue	  in	  oligomerization."	  PLoS	  Pathog	  8(6):	  e1002764.	  
  
Ziegler-Heitbrock, L., et al. (2003). "IFN-alpha induces the human IL-10 gene by 
recruiting both IFN regulatory factor 1 and Stat3." J Immunol 171(1): 285-290. 
  
 	   	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  158 
 
 
 
 
 
 
 
 
 
 
 
 
 
VITA 
 
 
 
SOUMYA GOVINDA REMESH 
 
                           Place of birth: Thrishur, Kerala, India 
                           Date of birth: April 28, 1985 
                           Citizenship: India 
 
 
 
EDUCATION: 
Doctor of Philosophy                                                                                    2010-2014 
Structural studies of Interferon Regulatory factor 4:  
A molecular perspective of its regulatory mechanism 
Department of Physiology and Biophysics  
Virginia Commonwealth University (VCU)  
Advisor: Dr. Carlos 
Escalante Assistant 
Professor  
Department of Physiology and 
Biophysics VCU 
 
 
 
  159 
Master of Science                                                                               2008-2010 
Insights into the catalytic mechanism of retro-aldol cleavage of β hydroxy amino acids 
by L-threonine aldolase 
Department of Medicinal Chemistry 
Virginia Commonwealth University (VCU) 
          Advisor: Dr. Martin Safo 
          Associate Professor 
          Department of Medicinal Chemistry 
          VCU 
 
Bachelor of Pharmacy                                                                        2004-2008 
University of Mumbai 
Mumbai Education Trust’s 
Institute of Pharmacy, Mumbai-400050 
India 
 
EXPERIENCE: 
 
Graduate Research Assistant                                                             2010-2014 
Department of Physiology and Biophysics 
Virginia Commonwealth University (VCU) 
Advisor: Dr. Carlos Escalante (cescalante@vcu.edu) 
 
Research Assistant                                                                            2009-2010 
Department of Physiology and Biophysics 
Virginia Commonwealth University (VCU) 
Advisor: Dr. Martin Safo (msafo@vcu.edu) 
 
RESEARCH SKILLS: 
 
1. Crystallography  
- Crystallization: Trained in use of Gryphon and Minstrel for setting up and monitoring of 
crystallization trials  
- Data Collection: In-house and at Synchrotron beam lines   
- Data Processing, Structure Solution and Refinement: Dtrek, hkl2000, Phenix, ccp4, Coot, 
Pymol, Refmac and Chimera 
 
2. Other Biophysical Techniques   
- Analytical Ultracentrifugation: Analysis using Sedfit, Sedphat programs  
- Small-Angle X-ray Scattering: Data Collection at beamlines   
- Analysis of SAXS data & generation of ab-initio models: Primus and ATSAS software 
suite  
 
 
  160 
3. Cloning and Protein Purification  
- Design and cloning of different protein constructs to be used for protein purification  
and other biochemical experiments, site-directed mutagenesis  
- Expression and purification of different proteins: Experience primarily in  
bacterial expression system with working knowledge of mammalian expression system  
- Trained in using Akta FPLC purification system for purification of proteins.  
 
4.   Biochemical Experiments   
- Use of SDS-Page gel electrophoresis and UV spectroscopic studies (analysis using 
Origin)  
- Western blot experiments   
- Circular Dichroism  
 
TRAINING: 
 
1. Trained to use the beamline X-4C and X-25 at National Synchrotron Light Source 
at Brookhaven National laboratory for X-ray crystallographic experiments.  
2. Trained to use the beamline X9 at NSLS at BNL to perform small angle X-ray 
scattering (SAXS) experiments.  
3. Attended SAXS workshops   
- UC Berkeley (Oct, 2013): 4th annual SIBYLS bioSAXS workshop, Advance Light 
Source (ALS) at Lawrence Berkeley National Laboratory, Berkeley, CA 
- Stanford (March, 2013): Workshop on SAXS, Stanford Synchrotron Radiation Lightsource  
at SLAC National Accelerator Laboratory Menlo Park, CA 
 
PUBLICATIONS: 
 
Based on work done during Master of Science in Pharmaceutical Sciences  
1. di Salvo Martino, Remesh SG et al, On the catalytic mechanism and 
stereospecificity of L-threonine aldolase; FEBS J, 2013  
 (Second author with equal contribution, structural work was part of my Master’s 
thesis project)   
2. A second untitled manuscript is in preparation (First author) 
  
Based on work done during my PhD in Biomedical Sciences  
1. Manuscripts in preparation to publish my graduate work   
2. Abstract Title: I woRk diFfently 4- Mechanism of activation of auto-inhibited 
IRF4   
 Abstract was published in Journal of Federation of American Societies for 
Experimental Biology (FASEB journal, April 2014, Vol. 28, Supplemental LB282)  
 
 
 
  161 
 
